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STELLINGEN 
behorende bij het proefschrift 
THE ROLE OF STRESS IN THE ETIOLOGY OF ASTHMA 
1. Puberteitsontwikkeling is niet verantwoordelijk voor de geslachtsgebonden verschillen in 
astmaprevalentie in de puberteit (dit proefschrift). 
2. Een genetische risicoscore is een goede methode om het risico op astma te schatten (dit 
proefschrift). 
3. Blootstelling aan psychosociale stress vroeg in het leven verhoogt de kans op de ontwikkeling 
van astma (dit proefschrift). 
4. Ochtendcortisolproductie speelt in de puberteitsfase geen rel in de ontwikkeling van astma 
(dit proefschrift). 
5. SNPs in genen die cortisol binden, namelijk NR3Cl en NR3C2, spelen geen rel in de 
ontwikkeling van astma (dit proefschrift). 
6. Onderzoeksresultaten genereren onderzoeksvragen. 
7. Don't waste your time, or time will waste you (Muse). 
8. Alie cliches zijn waar. Ook dat is een cliche. 
9. De kans dat alle hoogleraren statistiek het eens zijn is erg klein (Fokke en Sukke). 
10. Tim & Anne-Fleur bewijzen het: promotiestress tijdens de zwangerschap is niet altijd een 
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Asthma is a chronic inflammatory disease of the airways characterized by variable airway 
obstruction in association with increased airway hyperresponsiveness (AHR)1• Asthma is a 
serious global health problem and individuals of all ages are affected by this disease. Within 
adolescents aged 13-14 years, asthma prevalence world wide is estimated to be 14%2• Most 
asthmatics develop asthma during early childhood, with boys having a higher prevalence 
compared to girls. However, during puberty a gender switch in asthma prevalence occurs, 
with females having a higher prevalence than males3• After menopause, the gap in asthma 
prevalence between females and males becomes smaller, however, the female dominance 
does not fully disappear". 
Common symptoms of asthma are cough, wheeze and shortness of breath. These symptoms 
are caused by non-allergic stimuli, like fog, smoke and viral infections, and by exposure 
to allergens, such as house dust mite, (grass) pollens, fungi or air pollution. Exposure to 
these allergens results in an uptake by antigen presenting cells (APCs) which are presented 
throughout the whole respiratory tract5• These APCs activate T helper 2 (Th2) cells resulting 
in the production and secretion of cytokines (i.e. interleukin 3 (IL3), IL4, IL5, IL9, IL 13 and 
granulocyte macrophage colony-stimulating factor (GM-CSF))1• These cytokines lead 
among others to the activation of eosinophil maturation and survival, basophil recruitment 
and the production of immunoglobuline E (lgE) by B cells1 •5• After re-exposure to this antigen, 
the mast cells release numerous inflammatory mediators resulting in an acute inflammatory 
response. This acute inflammatory response consists of vascular leak, bronchospasm and 
activation of nociceptive neurons linked to parasympathetic reflexes, resulting in clinical 
symptoms of asthma including cough, wheeze and shortness of breaths. At the same time, 
some mast cell inflammatory mediators up-regulate expression of adhesion molecules for 
leucocytes (eosinophils, but also basophils and lymphocytes) on endothelial cells. These 
leucocytes are drawn to the airways by chemoattractant molecules released during a 
relatively symptom-free recruitment phase during the acute inflammatory response, where 
they release cytokines and tissue-damaging proteases which results in a second wave of 
airway inflammation, the so-called late inflammatory responses. The repetition of allergen 
exposure and the subsequent sequelae of memory T lymphocytes and eosinophils that 
are maintained by paracrine and autocrine cytokines stimulation, may contribute to airway 
hyperresponsiveness (AHR) and chronic airway symptomss. 
Complete control of the disease is the main goal of asthma management and this is achieved 
among others with medication. Asthma symptoms during an acute attack are treated with 
short-acting �2-sympathicomimetics, which act quickly to reverse bronchoconstriction and 
relief symptoms of asthma. Depending on the severity of asthma, individuals with asthma 
are additionally being treated with maintenance medication at an early stage, such as 
glucocorticosteroids (modulating Th2 cytokines and their associated airway inflammation) 
which are taken prophylactic to control symptoms of asthma7• These inhaled corticosteroids 
are prescribed either alone or in combination with long-acting sympathicomimetics, 
depending on the severity of the disease. 
Nowadays, asthma is not considered as one single disease, but it encompasses multiple 
subgroups, or phenotypess. In most asthmatics the inflammatory response as a result of 
exposure to a certain allergen is marked by the Th2 inflammatory response as described 
above. Asthma phenotypes that belong to this Th2-associated asthma are among others 
early onset allergic asthma, nocturnal asthma and exercise-induced asthmas. Early onset 
allergic asthmatics develop their asthma during early life, are atopic (produce lgE when 
exposed to an allergen) and have mostly other allergic diseases such as rhinitis or eczema 
and/or a family history of allergic diseasess. Asthmatics with nocturnal asthma have 
specifically symptoms of their asthma during midnight which typically reflects more sever 
asthma, or asthma without control. This is associated with more severe inflammation at 
day and night and in some aspects more inflammation during the night, which is then less 
counterbalanced by the lower autonomous nervous system drive as is present at night9•1 0• 
Asthmatics with exercise-induced asthma have complaints of their asthma particularly 
during or specifically after stopping their exercises. 
Although inhaled corticosteroids are the mainstay in asthma treatment, not all asthmatics 
develop full asthma control with this treatment. This indicates that not all asthma is associated 
with a Th2 inflammatory response, the so-called non-Th2-asthmas. Although little is known 
about this non-Th2-asthma subgroup, it meets the criteria for asthma. This group presents 
itself generally with less airway obstruction and AHR than individuals belonging to the Th2-
asthma group. Specific phenotypes of this non-Th2-asthma group include very-late onset 
asthma, obesity associated asthma and neutrophilic asthmas. 
FACTORS ASSOCIATED WITH THE DEVELOPMENT OF 
ASTHMA 
With regard to asthma development, it is known that many pathways are potentially 
involved in its etiology. Not only multiple genes belonging to several biological pathways 
(i.e. genes implicated in Th2 cell differentiation and allergic inflammation (i.e. interleukin 
(IL) 4, interleukin 4 receptor (/L4R), /L13)11-14 or airway remodeling (A Disintegrin And 
Metalloprotease 33 (ADAM33)15·19}, but also environmental factors (i.e. exposure to tobacco 
smoke20 or air pollution21} and gene-environment interactions are known to be associated 
with the development of asthma or asthma-related phenotypes. However, these factors 
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do not fully explain the increasing incidence of asthma that has occurred during the past 
decennia. Therefore, hypotheses on determinants other than those addressing genetic 
predisposition, environmental exposures and gene-environment interactions have been put 
forward. 
Historically, asthma has been defined as a psychosomatic disorder. In the first half of the 
20th century, leading physicians believed that psychological determinants, and especially 
the quality of mother-child interaction, played a role in the etiology of asthma. As a 
reaction to these overhyped claims, and with the emerging understanding of the chronic 
inflammatory process underlying asthma, researchers almost unanimously discarded the 
role of psychological factors in asthma development. Psychosocial research towards asthma 
has since then focused on the importance of the asthma patient's behavior with regard to 
coping with his or her illness. These studies have resulted in very valuable knowledge with 
important implications for health care22·24• One example is the fact that psychosocial distress 
or negative affect influence the perception of the seriousness of their asthma which result 
in an overuse of asthma medication. Knowing that such psychosocial mechanisms may 
contribute to overuse of medication has implications for educating patients on asthma self­
management23. 
In the past decade general practitioners, pulmonologists and respiratory researchers 
started to reconsider the role of stress in asthma. Developments in the relatively new field 
of psychoneuroimmunology, linking psychosocial stress, the central nervous system, and 
alterations in immune and endocrine function, provided plausible biological pathways that 
pinpoint to a role of stress in the etiology of asthma. These new insights have led to a 
paradigm shift that reconsiders the role of psychological determinants in the etiology of 
asthma, and focuses on the overlap between biological determinants and psychosocial 
factors in trying to understand the etiology of asthma. In contrast to earlier psychoanalytic 
theories, current theories assume psychosocial stress to confer a risk for the development 
of asthma, additionally to risk factors such as genetic predisposition, and intermediate 
asthma phenotypes like sensitization to allergens and AHR. 
Indeed, a number of recent cross-sectional and longitudinal studies performed in children, 
adolescents and adults investigated stress as a cause of asthma. These studies investigated 
a broad variety of stressors, ranging from exposure to stress experienced by the individual 
itself (i.e. stressful life events, abuse or job stress) to exposure to stress experienced by 
others such as the parents (i.e. maternal anxiety or depression or parental difficulties). 
Results from cross-sectional studies found that exposure to violence, physical/sexual 
abuse, childhood adversities, and job stress was associated with asthma. Another study 
showed that exposure to domestic violence of the mother was associated with asthma in 
her children or young adult25. Moreover, exposure to domestic violence in women was also 
associated with asthma in the women themselves25·26• However, no association was found 
between exposure to community violence and asthma in children27• Other studies found that 
exposure to physical or sexual abuse was associated with asthma in children and adults27•28• 
Childhood adversities29 and exposure to job stress30 were also found to be associated with 
asthma in adults (Tables 1.1 and 1.2). However, when investigating stressful life events 
as a sum score of different life events, the association between exposure to stressful life 
events and asthma is less clear. One cross-sectional study found an association between 
stressful life events and asthma in adolescents31 , whereas another study did not find such 
an association in children and adolescents32• A close comparison of these studies revealed 
that all studies investigated different stressful life events which hampers comparison of the 
results from these studies (Tables 1.1 and 1.2). 
Summarizing, results from cross-sectional studies suggest that there indeed exists an 
association between stress and asthma, but no conclusion can be drawn about the causal 
direction of this association. Recently, longitudinal studies are performed that studied the role 
of stress in asthma development. Results from birth-cohort studies showed that exposure 
to psychosocial stress during early life increased the risk to develop asthma. These studies 
typically investigated the role of parental stress exposure on asthma development in their 
child and found that maternal anxiety during pregnancy33, maternal exposure to the death of 
a child or spouse during pregnancy34, parental difficulties measured at 3 wk of age35•36 , long 
term maternal distress (anxiety or depression}37, stressful life events during 1 year preceding 
delivery38 and chronic intimate partner violence39•40 were associated with an increased risk 
to develop asthma in their children (Table 1.1 ). Next to birth-cohort studies, the role of 
stress exposure on asthma development was also studied in longitudinal studies performed 
in children and adults. Results from these studies revealed that exposure to community 
violence41 increased the risk of asthma development in children, and exposure to stressful 
life events42•43, war-related stress44, work stress45 and stress in daily life46 increased the risk 
of asthma in adults (Tables 1.1 and 1.2). 
Although the evidence is accumulating that psychosocial stress is involved in the etiology 
of asthma (Tables 1.1 and 1.2), a number of important questions remain and have to 
be clarified regarding the role of the occurrence versus the impact of the stressors, the 
timing of the exposure to stress and the modification of the effect of stress by genetic 
susceptibility. In addition, also the mechanisms via which psychosocial stress leads to 
asthma development need to be clarified. Stress exposure may exert its influence on many 
levels, making it difficult to disentangle the different mechanisms via which stress relates 
to asthma development and severity, especially in cross-sectional studies. Stress effects 
can be classified into (1) physiological stress effects, (2) behavioural stress effects, and (3) 
psychological stress effects. Of interest, stress has been proposed to affect asthma via all 
of these pathways. 
15 
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TABLE 1.1 I Overview of studies investigating association between psychosocial stress and asthma/asthma development in children and adolescents 
Maternal anxiety during pregnancy 
Cookson33 Prospective birth-cohort Maternal anxiety at Current asthma at age Maternal anxiety during pregnancy was 
study of 5,810 children 18 and 32 weeks of 7,5 yrs associated with increased risk of asthma onset 
gestation and 8 months during childhood 
of age 
Bereavement 
Khashan34 Prospective birth-cohort Prenatal exposure to Asthma from hospitalized Prenatal exposure to maternal bereavement 
study of 3,290,141 maternal bereavement1 patients was associated with an increased risk of 
children hospitalization for asthma 
Parental stress/caregiver stress 
High risk cohort 
Mrazek35 Prospective birth-cohort Parental difficulties Asthma onset at age 3 Parental difficulties measured at 3 wks of age 
study of 150 genetically measured at 3 wk of age yrs predicted an increased risk of asthma onset by 
predisposed children 3 yr of age 
Klinnert36 Prospective birth-cohort Parental difficulties Asthma onset between Parental difficulties measured at 3 wk of age 
study of 150 genetically measured at 3 wk of age age 6-8 yrs were associated with an increased risk for 
predisposed children asthma onset between age 6- 8 yrs 
Non-high risk cohort 
Kozyrskyj37 Prospective birth-cohort Maternal distress2 during Asthma at age 7 yrs Long term maternal distress was associated 
study of 13,907 children the first year of life and with an increased risk for asthma at age 7 yrs 
onward 
Klinnert38 Prospective birth-cohort 
study of 150 genetically 
predisposed children 
Cohen27 Cross-sectional study of 
1,213 children 
Turyk31 Cross-sectional study of 
1,860 adolescents 
Kilpelainen32 Cross-sectional case-
control study of 10,667 
adolescents 
Cohen27 Cross-sectional study of 
1,213 children 
Stressful life events 
High risk cohort 
Stressful life events3 Asthma onset by age 3 
during 1 year preceding yrs 
delivery of the child 
Non-high risk cohort 
Major life stressors4 Current asthma 
during the previous year 
Stressful life events5 Asthma 
Stressful life events6 Asthma (age of onset) 
during their life 
Traumatic events/abuse 
Traumatic events7 in the Current asthma 
previous year 
...... � General Introduction 
Stressful life events in absence of sufficient 
parenting mechanisms increased the risk of 
asthma onset by age 3 yrs 
No association between stressful life events 
and asthma 
Asthma was significantly associated with 
number of total life events, family and violent 
events, but not with school events 
No association between preceding stressful life 
events and asthma 
History of physical or sexual abuse was 
associated with an increased risk for asthma 
I-> 
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TABLE 1.1 I Continued 
Violence 





92,486 households mother 
Cross-sectional study of 
1,213 children 
Prospective birth-cohort 
study of 3,116 children 
Prospective birth-cohort 
study of 3, 116 children 
Longitudinal multilevel 
study of 2,071 children 
aged 0-9 yrs 
Community violence in 
the previous year 
Maternal intimate partner 
violence after birth, 12 
and 36 months of age 
Maternal intimate partner 
violence after birth, 12 
and 36 months of age 
Life time exposure to 
community violence 
Current asthma 
Asthma at age 36 months 
Asthma at age 36 months 
Having ever been 
diagnosed with asthma 
Domestic violence of the mother was 
associated with asthma in children 
Domestic violence of the mother was 
associated with asthma in adolescents 
No association between exposure to 
community violence and asthma 
Chronic intimate partner violence (IPV) is 
associated with an increased risk for asthma at 
age 3 yrs 
In an analysis stratified by mother-child 
activities (MCA), children with mothers exposed 
to chronic IPV and a low level of MCA had a 
higher risk to develop asthma compared to 
those exposed to chronic I PV but with a higher 
level of MCA 
After adjusting for housing deterioration8, 
housing disarray9 and housing hardship10 the 
association between IPV (12 or 36 months) 
and asthma was no longer significant, however, 
exposure to IPV during both time points was 
significantly associated with asthma 
Community violence is associated with an 
increased asthma risk 
1 Death of spouse or child. 2 Depression or anxiety. 3 FILE= Family Inventory of Life Events (71 life events). 4 1.e. death of a family member and parents' 
divorce. 5 1.e. family/relationship difficulties, school difficulties and experiencing violent events. 6 I.e. disease or death of a family member and conflict in 
personal or parental relationships (preceding = asthma after exposure to stressful life events, concomitant = asthma and exposure to stressful life events 
in the same period, subsequent= asthma before exposure to stressful life events). 7 I.e. abuse, neglect and excessive fear of adults "in charge". 8 I.e., 
peeling paint, holes in floor and broken windows. 9 I.e. dark, cluttered, crowded or noisy house. 10 I.e. Moving repeatedly and hardships in keeping the 
house warm. 
TABLE 1 .2 I Overview of studies on the association between psychosocial stress and asthma/asthma development in adults 






Prospective cohort study 
of 16,881 adults 
Prospective study of 
4,010 adults 
Cross-sectional case­
control study of 354 adult 
women 
Prospective study of 
2,066 adults 
Stressful life events1 
between baseline and 
first follow-up 
Stressful life events2 
during the last 5 years 
before the baseline 
measure 




Childhood sexual abuse Asthma/breathing 
Childhood physical abuse problems in the previous 
Adult sexual abuse 12 months 
Adult physical abuse 
War-related stress during Incidence asthma 
the Kuwait invasion 
Stressful life events were associated with 
asthma 
Illness of a family member, marital problems, 
divorce or separation, and conflicts with a 
supervisor were associated with asthma 
Breaking off a life partnership was associated 
with asthma 
Childhood sexual abuse was associated with 
asthma 
Childhood physical abuse was not associated 
with asthma 
Adult sexual abuse was not associated with 
asthma 
Adult physical abuse was not associated with 
asthma 
War-related stress was associated with asthma 
incidence 
Childhood adversities (combination stressful life events and traumatic events) 
Cross-sectional study of 
18,303 adults 
Childhood adversities3 Adult onset asthma (>21 Experience of two or more childhood adversities 
before adulthood yrs) were associated with adult-onset asthma 
Physical abuse, parental death, parental mental 
disorder, and family violence were associated 
with adult-onset asthma 
� General Introduction 
TABLE 1 .2 I Continued 
N 
0 Chapter 1 
Violence 
Subramanian25 Cross-sectional study of 
92,486 households 
Domestic violence to the Asthma prevalence 
Loxton26 
mother 
Cross-sectional survey of Domestic violence 
1 4, 1 00 adult women 
Asthma 
Domestic violence to the mother was 
associated with asthma in this mother 
Domestic violence to their mother was 
associated with asthma in young adults 
Domestic violence was associated with asthma 




Cross-sectional study of 
2,903 adults 
Prospective study of 
3,027 adults 
Prospective cohort study 
of 10,615 adults 
Job stress 
Work stress during 
current or last job 
Inability to relax after 
work during current or 
last job 
Stress in daily activities 
Current asthma 
Adult-onset asthma 
Cumulative incidence of 
asthma 
Asthma incidence 
Very or extremely stressful jobs were 
associated with current asthma and adult-onset 
asthma 
Work stress and inability to relax after work 
were both associated with asthma 
Stress in daily activities was not associated with 
asthma incidence 
1 I.e. death of a family member, emotional, physical or sexual violence, severe illness in a family member, death of the mother, a major increase in marital 
problems, divorce or separation, severe conflicts with a supervisor, severe financial difficulties and death of the father. 2 I.e. unemployment, having 
broken off a life partnership and death of someone close. 3 Combination of stressful life events and traumatic events. 
THE ROLE OF STRESSOR OCCURRENCE VERSUS 
IMPACT OF STRESSORS 
To give a simple definition of "stress" has been proven to be extremely difficult47• Stress 
has been defined as environmental demands that individuals appraise as exceeding their 
coping abilities47 • This definition clearly indicates that stress comprises two components: 
the presence of a stressor (i.e. a demand from an individual's environment) and the 
subjective experience of stress due to the presence of this stressor (i.e. the appraisal that 
the stressor exceeds the coping abilities) . So far, in studies on the role of stress as an 
additional determinant to the development of asthma, a broad variety of operationalizations 
and definitions of psychosocial stress have been used, such as exposure to maternal 
anxiety during pregnancy, parental difficulties, stressful life events such as illness or death 
of a close relative, traumatic events such as physical or sexual abuse, violence, childhood 
adversities, stress in daily life and work-related stress. Thus, some studies used rather 
objective measures (e.g. death of a close relative), whereas others studied used more 
subjective judgments of stress (e.g. parental difficulties). Moreover, the same stressor 
might be perceived differently by different individuals due to stress coping resources. These 
stress coping resources may be related to an individual's characteristics (e.g. personality) 
and/or his or her environment (e.g. family functioning). This makes comparison of results 
from different studies difficult. 
THE TIMING OF EXPOSURE TO STRESS 
There are two basic conceptual life course models, being ''the critical period" model and 
''the accumulation of risk" model48, which can be applied to the stress-asthma association. 
The critical period model underlies the fetal origins of adult disease hypothesis. Especially 
the perinatal period is an important period in the development of asthma, since both the 
lung and the immune system develop during this period49• Previous studies indeed found 
that exposure to stress during this period was associated with an increased risk of asthma 
development. These studies typically investigated asthma development in relation to 
maternal anxiety during pregnancy33, maternal exposure to the death of a child or spouse 
during pregnancy34, stressful life events during 1 year preceding delivery38 , and parental 
difficulties measured at 3 wks of age35•36 (Table 1.1 ). Thus, results from these studies 
suggest that the perinatal period is a critical period in the development of asthma and that 
the critical period model can be applied to the stress-asthma association. However, other 
studies showed that there are also associations between asthma and stress exposure after 
this perinatal period. These studies investigated asthma development in relation to long­
term maternal distress (anxiety or depression)37, chronic intimate partner violence39•40, life 
time exposure to community violence41 , stressful life events within the previous 5 years 
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(i.e. i l lness of a family member, marital problems, divorce or separation, conflicts with a 
supervisor42 or break off a life partnership43) , war-related stress44 and work related stress45 
(Tables 1 . 1 and 1 .2) . Therefore, it remains unclear whether the effect of stress exposure on 
asthma development is different for the d ifferent periods, e .g. whether it is larger when the 
exposure took place during the perinatal compared to later in life. 
The other model is the accumulation of risk model. In this model ,  the effects of stress 
accumulate gradually over time. Evidence for this model comes from a previous study that 
showed that the effect of severe life events, especial ly in the presence of multiple chronic 
stressors, increases the likelihood of asthma exacerbation in children aged 6-1 3  years50• 
Whether this accumulation of risk model also appl ies for the development of asthma is yet 
not clarified. 
THE EFFECT OF STRESS AND GENETIC SUSCEPTIBILITY 
A well-known model in psychiatry is the stress-vulnerabil ity model ,  which basically states 
that stress may lead to psychiatric problems if an underlying vulnerability is present. Previous 
studies performed in children with a famil ial predisposition for asthma found that exposure 
to psychosocial stress is associated with an increased risk to develop asthma (Table 1 . 1 ). 
However results from population-based studies are inconsistent. Most studies found an 
association between stress exposure and asthma development, however, some studies did 
not (Tables 1 . 1 and 1 .2) . This could suggest that a familial predisposition for asthma may 
modify the association between psychosocial stress exposure and asthma development. 
However, plausible genes underlying this potential ly modifying effect are yet unknown. 
THE MECHANISMS VIA WHICH STRESS CONTRIBUTES 
TO ASTHMA DEVELOPMENT 
Physiological stress effects 
The effects of stress on physiology are mediated by the fast-acting autonomic nervous 
system (ANS) (including the sympathetic and parasympathetic branches) and the slower­
acting hypothalamus-pituitary-adrenal (HPA) axis, the two axes that link the brain and the 
immune system. 
Autonomic nervous system (ANS) 
The ANS controls activities of visceral functions that are not under voluntary control , such as 
the regulation of the circulation (heart rate and force of contraction) , respiration, digestion, 
body temperature, papillary dilation, and metabolism. The ANS consist of two branches: the 
sympathetic neNous system (SNS) and the parasympathetic neNous system (PNS). The 
SNS activates neurons in the thoracic and lumbar levels of the spinal cord and activation 
of this system leads to the release of catecholamines (CAs: adrenaline and noradrenaline). 
The PNS activates neurons in the cranial and sacral levels of the spinal cord and activation 
of this system leads to the release of acetylcholine. Most organs are inneNated by neurons 
of both systems, however, the function of these systems on these organs is usually opposite 
(e.g. SNS increases heart rate and induces bronchodilatation, whilst PNS decreases heart 
rate and induces bronchoconstriction)51 ·53• 
The Hypothalamus-Pituitary-Adrenal (HPA) axis 
Activation of the neurons in the paraventricular nucleus (PVN) of the hypothalamus leads to 
the secretion of corticotrophin releasing hormone (CRH). This CRH stimulates the anterior 
pituitary gland resulting in a secretion of adrenocorticotropin hormone (ACTH), which 
stimulates the adrenal glands to produce cortisol. This whole process from activation of the 
PVN to the release of cortisol from the adrenal glands takes about 20-30 minutes53• In non­
stressful situations, the secretion of cortisol follows a circadian rhythm, with a sharp increase 
prior to awakening, reaching a peak approximately half an hour later (cortisol awakening 
response (CAR)54•55) ,  after which the secretion of cortisol steadily declines and is at its 
lowest during midnight. Exposure to stress leads to an increase in the activity of the PVN 
resulting in an increase in cortisol production. Overshooting of the HPA axis is regulated 
by means of a negative feedback mechanism, meaning that elevated circulating levels of 
cortisol suppress secretion of both CRH and ACTH, resulting in a decreased secretion of 
cortisol53•56 • Cortisol thus plays an important role in the regulation of the basal HPA axis 
activity and in the duration of the stress response53• In the human body, cortisol influences 
the activity of many systems, including the central neNous system, where it is involved in 
learning, memory and emotion; the metabolic system, where it regulates glucose storage 
and utilization; and the immune system, where it regulates the magnitude and duration of 
the inflammatory responses and the maturation of lymphocytes53•57• 
The link of these systems with asthma development 
The effect of stress on asthma development is complex. Acute stress activates both the SNS 
and HPA axis, leading to an increased secretion of CAs and cortisol. Both CAs and cortisol 
play a key role in the immune system, where they induce a shift in the Th1ffh2 balance of 
the peripheral mononuclear blood cells towards a predominant Th2 response52•53 • Moreover, 
CRH is also produced in the periphery at the site of inflammation52•53• Especially in the early 
inflammatory response after allergen inhalation, this peripheral CRH plays an important 
role52• Peripheral CRH activates mast cell degradation leading to the release of histamine, 
causing vasodilatation, edema and bronchoconstriction52•53• In addition, histamine inhibits 
the production of Th1 cytokines52• Thereby, activation of peripheral CRH induces acute 
inflammation and a shift in the Th1ffh2 balance towards a Th2 response52 • In this way, 
exposure to acute stress leads to an activation of the stress system and together with the 
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peripheral production of CRH this facilitates asthma development. However, these effects 
of stress on asthma development can be antagonized by the direct effect of stress on 
mast cells. Both cortisol and CAs act directly on mast cells leading to a suppression of the 
release of histamine and thereby abolishing its inflammatory and bronchoconstrive effect52• 
Moreover, the activation of the SNS by stress leads to bronchodilatation. 
Results from previous studies suggests that exposure to stress in a risk factor for asthma 
development33-36•38•46 • However, it is yet unclear whether asthma development is associated 
with high or low cortisol levels. Some studies found that asthmatics had high cortisol 
levels compared to non-asthmatics58•59 , whereas other studies found no difference60•64 
or even lower65·67 cortisol levels in asthmatics compared to non-asthmatics. One recent 
review stated that a blunted HPA axis (characterized by lower morning cortisol levels and 
flattening of the diurnal slope) is associated with an increased susceptibility to autoimmune 
and inflammatory diseases49, and therefore low cortisol levels are associated with asthma. 
However, how these low cortisol levels lead to the development of asthma is yet not clear. 
The role of the autonomic nervous system in relation to asthma has also been studied. That 
study suggested hat patients with asthma have an increased activity of the parasympathetic 
and decreased activity of the sympathetic nervous system68• However, the role of the ANS 
in asthma development has to be studied further. 
Behavioural stress effects 
Stress increases the likelihood of health-risk behaviors such as smoking and behaviors 
related to overweight (both eating and low activity patterns). Adolescents with a history of 
stressful events early in life have an increased risk for regular smoking69 , a known risk factor 
24 for asthma. Exposure to early life trauma is also associated with obesity later in life70, and a 
meta-analysis indicated it to be a risk factor for asthma71 • Thus, smoking and overweight are 
potentially mediating factors in the relation between early life stress and asthma. 
Psychological stress effects 
Stress effects on physiology and behavior may directly worsen the level of lung function. 
However, there may be large variations in the resulting severity of dyspnea perceived by 
patients. Dyspnea perception in general does not directly relate to the level of objectively 
measured lung function72; processes such as attention to or interpretation of somatic 
symptoms may bridge this gap. Several studies show that exposure to stress might lead 
to biases in these processes and thus to substantial differences in dyspnea perception73•75• 
Stress and associated mood effects might trigger (or attenuate) a process of turning inward, 
thereby increasing attention towards the self, leading to a lower threshold for symptom 
perception. For example, anxious asthma patients tend to overperceive dyspnea76• In this 
context, one should keep in mind that physician diagnoses are based primarily on the 
presentation of symptoms to the physician. 
THE TRACKING ADOLESCENTS' INDIVIDUAL LIVES 
SURVEY (TRAILS) STUDY 
The association between stress and asthma will be studied in the TRacking Adolescents' 
Individual Lives Survey (TRAILS, see also www.trails.nl). TRAILS is a population-based 
cohort study including inhabitants of five communities in the North of the Netherlands, born 
between October 1st 1989 and September 30th 1990 (n=2,230). These adolescents are 
being studied biannually from age 1 O at least until age 25, in order to assess the development 
of mental and somatic health from preadolescence into adulthood. Data covering the child's 
life before the age of 1 O are collected from registries (e.g. youth health care), retrospective 
questionnaires and interviews. This includes data concerning pregnancy, birth weight, and 
growth and development during childhood. The key objective of TRAILS is to chart and 
explain the development of mental health from preadolescence into adulthood. As part of 
the enriching TRAILS program, blood, DNA and variables related to somatic health are 
collected. Detailed information has been described in Huisman et al . 20oan. 
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TABLE 1.3 1 Time schedule and variables under study 
Determinants Pubertal development (Tanner) 
Cortisol (basal) 
Perinatal stress (in utero exposure to 
maternal psychological problems) 
Postnatal stress (postnatal depression) 
Stressful life events before age 4 years 
Birth weight 






O'l Chapter 1 
Pubertal development (Tanner and Puber- Pubertal development (Tanner and Puber-
tal Development Scale) tal Development Scale) 
Cortisol (basal and stress-induced) 
Unpleasant events experienced between Genetic data (IL4, IL4R, IL 13, CDH1, 
ages 0-5 and 6-11 years PCDH1, ADAM33, NR3C1, NR3C2) 
In utero exposure to maternal smoking 
Asthma Asthma 
Asthma (European Community Respira-
tory Health Survey (ERCHS)) 
Hay fever Hay fever 
Allergy Allergy 
Eczema Eczema 
AIMS AND OUTLINE OF THE THESIS 
The aims of this thesis are to unravel the path from early life stress to the development 
of asthma up to adolescence, and to quantify the relative contribution of the mediating 
mechanisms via which stress leads to asthma development. However, before we study 
these aims, we first focus on the role of pubertal development in the gender-related switch 
in asthma prevalence, and on the genetic pathways involved in asthma development. 
Chapter 2 describes the development of asthma up to adolescence. Specifically, the role 
of age and pubertal development in the gender-related switch in asthma prevalence will 
be studied. In addition, the association between pubertal development and asthma-related 
phenotypes, such as total IgE and peak expiratory flow fall during a shuttle run test, will be 
studied. 
In chapter 3, early life risk factors for asthma development are studied. These include 
the combined effect of single nucleotide polymorphisms (SNPs) in genes involved in the 
development of asthma and asthma-related phenotypes (genetic risk score) on asthma 
development. The predicting properties of this genetic risk score will be compared to the 
predicting properties of know early life risk factors of asthma development such as in utero 
exposure to maternal smoking and maternal asthma. 
In chapter 4, the role of exposure to perinatal stress and stress during early childhood on 
asthma development up to adolescence will be studied. In addition, in utero exposure to 
maternal smoking and birth weight will be studied as mediators in this association. 
Chapter 5 and 6 concern the role of the HPA axis in asthma and asthma development. 
In chapter 5, the role of basal cortisol levels and cortisol levels under psychosocial stress 
in relation to the presence and development of asthma is studied. Chapter 6 investigates 
whether SNPs in the mineralocorticoid or glucocorticoid receptor influence asthma risk. 
The results of these chapters are summarized and discussed in chapter 7, which will 
conclude with some implications of this research for further studies towards the role of 
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ABSTRACT 
Background: During puberty, a gender shift in asthma prevalence occurs, with a 
preponderance of boys before puberty. The mechanisms underlying this gender shift are 
unclear. We assessed associations of pubertal stages and transition through puberty with 
(1) the prevalence, incidence, and remission of asthma in male and female subjects, (2) 
total lgE levels, and (3) peak expiratory flow (PEF) fall during a shuttle run test (SRT). 
Methods: In the TRacking Adolescents' Individual Lives Survey study (n=2,230; 51 % 
female subjects), associations between pubertal stages and the prevalence, incidence, and 
remission of asthma were tested by using logistic regression and generalized estimating 
equations at a mean ± SD age of 11.1 ± 0.6, 13.6 ± 0.5, and 16.3 ± 0. 7 years. Multiple 
linear regression analysis were used to study log-transformed total lgE levels and PEF fall 
during a SRT dependent on early versus late pubertal stages at a mean age of 16.3 years. 
Results: The prevalence of asthma was similar in boys (7.7%) and girls (7.4%) at a mean 
age of 11.1 years. The prevalence of asthma was significantly higher in female (6.2%) 
than male (4.3%) subjects at 16.3 years of age. There were no significant associations 
between transition of pubertal stages and the presence of asthma, either cross-sectionally 
or longitudinally. Pubertal stages and log-transformed total lgE levels or PEF fall during a 
SRT at age 16.3 years were not correlated. 
Conclusions: A shift in the prevalence of asthma occurs between 11.1 and 16.3 years, 
which is due to both an increased incidence and decreased remission of asthma in female 
compared with male subjects. Pubertal stages could not be proved to explain the gender 
shift in asthma prevalence. 
INTRODUCTION 
Asthma is a chronic inflammatory disease of the airways. Before puberty, the prevalence 
of asthma is higher in boys than in girls. By adulthood, a gender switch in the prevalence 
of asthma has occurred, with female subjects having a higher prevalence than male 
subjects1 ·5_ The exact age at which this switch occurs has not been identified, and a number 
of age ranges have been described with respect to the changing ratio of asthma6• Health 
care utilization related to asthma is significantly higher in male subjects aged 2 to 13 years, 
whereas it is greater in female subjects older than 23 years6• Additionally, boys with asthma 
are significantly more often hospitalized than girls until the age of 14 years, whereas the 
opposite is true in adulthood7• Because this change in male/female ratio occurs during 
puberty, hormonal changes throughout this period of life have been thought to be potential 
causative factors for the onset of asthma. 
Female sex hormones have been linked to the development of asthma. In female subjects 
the risk of asthma is increased for those with early-onset menarche5•8• This effect might be 
due to higher exposure to cumulative female sex hormone concentrations in early-onset 
compared with late-onset menarche5•9•10• A longitudinal study showed that pregnancy, a 
state in which both progesterone and estrogen levels are increased, is also linked to the 
development of asthma 1 1 • However, cross-sectional studies did not show this association 1°. 
A role for female sex hormones is also suggested by the fact that after menopause the 
incidence of asthma is decreased in female subjects when compared with that seen in 
premenopausal women or men12•1 3• 
Female sex hormones have also been linked to asthma morbidity. Approximately 30% to 
40% of female asthmatic subjects experience perimenstrual asthma worsening10•14, which 37 
associates with increased symptoms15 and a greater l ikelihood of hospitalization14• The 
exact mechanism behind this perimenstrual worsening is not clear, but it might involve the 
increase in progesterone and estrogen levels during the luteal phase, leading to increased 
inflammation of the airway wall10•16• Because oral contraceptives (OCs) suppress the 
increase in estrogen and progesterone levels during the luteal phase, the role of OCs on 
perimenstrual asthma has been studied. These studies suggest a small favorable effect of 
OCs on perimenstrual asthma and mild asthma8•14; however, in women with more severe 
asthma, symptoms are increased10•17• Studies assessing the role of pregnancy on asthma 
morbidity produced conflicting results10• In an equal number of women with mild asthma, 
asthma symptoms improved, remained stable, or deteriorated, and only in the more severe 
cases of asthma did asthma symptoms increase12•18• 
Animal studies suggest that male hormones play a role in asthma development as well. 
Male androgens might protect against the development of asthma19 • Murine models of 
allergic airway disease show that male animals are less likely than female animals to have 
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airway inflammation20• Castrated mice have low blood levels of  testosterone and develop 
more severe airway inflammation than sham-operated mice, and their airway inflammation 
is comparable with that seen in female mice20• It is possible that higher testosterone levels 
in sham-operated mice lead to systematic inhibition of the Th2 cell response and hence 
less severe airway inflammation20• Furthermore, administration of progesterone increases 
eosinophi l ic airway inflammation in male mice21 • These animal models suggest that 
changing levels of male and female sex hormones influence the level of inflammation in 
both male and female mice. 
Contrary to the apparent role of hormones shown in animal studies, the effect of changing 
levels of sex hormones on asthma is less clear cut in human subjects5 • To our knowledge, 
only one study directly related the stage of puberty to the prognosis of asthma3, but because 
this study was performed in adolescents with asthma, the association between pubertal 
stages and asthma incidence could not be studied. 
As far as we know, no studies thus far have investigated the role of sex hormones on 
the development of asthma longitudinally. This is important because only with longitudinal 
methods can the association between hormonal changes during transition through puberty 
and the net change in the prevalence of asthma over time (net result of incidence and 
remission) be studied. We performed a prospective cohort study on the effect of changes 
in pubertal stages on asthma as a proxy for the hormonal changes that occurred during the 
ages of 1 1  to 1 6  years, the period in which transition through puberty takes place. 
The aim of the current prospective study was to assess gender differences in the prevalence, 
incidence, and remission of asthma during transition through puberty. Additionally, we 
investigated gender differences in objective asthma-related phenotypes (total lgE levels 
and peak expiratory flow (PEF) fall after a shuttle run test (SRT)) in relation to the pubertal 
stage at a mean age of 1 6.3 years. 
METHODS 
Study population 
The TRacking Adolescents' Individual Lives Survey (TRAILS) is a prospective cohort 
study among adolescents in the general Dutch popu lation. Thus far, 3 surveys have been 
completed: survey 1 in 2001 -2002 (mean ± SD age 1 1 . 1 ± 0.6 years), survey 2 in 2003-
2004 (mean ± SD age 1 3.6 ± 0.5 years), and survey 3 in 2005-2007 (mean ± SD age 
1 6.3 ± 0.7 years) . Adolescents will be followed until at least the age of 24 years. Detailed 
information has been described elsewhere20•23• 
Questionnaire data 
Data were collected on the presence of asthma, pubertal development (all 3 surveys), birth 
weight (first survey), cigarette smoking during pregnancy (third survey) , and the use of 
OCs (third survey) (Table E2.5 in online supplement). Asthma was defined as a parentally 
reported physician's diagnosis of asthma and/or having symptoms of asthma and/or use 
of asthma treatment prescribed by a physician in the past 12 months. Incidence of asthma 
was defined as having asthma at a specific survey while not having asthma at the previous 
survey. Remission of asthma was defined as having asthma at a specific survey but not at 
the following survey. 
Clinical characteristics 
Height and weight were measured by using standardized protocols24• At each survey, body 
mass index (BMI) was calculated. Obesity is a risk factor for the development of asthma25• 
Therefore BMI was categorized as normal weight, overweight, and obesity based on age­
and sex-specific cutoff points26• 
Total lgE 
At the third survey (mean age, 16.3 years), 1,206 (66.4%) adolescents gave blood to 
determine serum total lgE levels. 
Twenty-meter SRT 
At the third survey, 629 (34.6%) adolescents completed a 20-m SAT, a reliable test to 
provoke exercise-induced asthma27• This test comprises running a 20-m track back and 
forth, starting at a speed of 8 km/h and increasing by 0.5 km/h every minute28•29• 
Heart rate monitoring was performed in a subsample of 241 (38.3%) adolescents who 
performed the SAT by using a Polar Team System type 1 as a control for maximal 
performance. The vast majority of the adolescents (>95%) performed a maximal test ( � 185 
beats/min). 
PEF measurements were performed before and after the SAT by using aMini-Wright PEF 
meter. The highest PEF of 3 measurements both before and after the SAT were used in the 
analysis. PEF fall was calculated as the difference between PEF after and before the SAT 
divided by PEF before the SAT. 
Pubertal stages 
Two measurements of pubertal development were used in this study: the Tanner stages of 
pubertal development30·31 , which were filled in by the parents at the first and second survey, 
and the Pubertal Development Scale (PDS) questionnaire32•33, which was answered by the 
adolescents at the second and third surveys. The Tanner stages of pubertal development 
consist of schematic drawings of secondary sex characteristics (pubic hair and breast 
development for female subjects and pubic hair and genital development for male subjects). 
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A parent (usually the mother) selected the drawings that matched most closely to the actual 
pubertal development of the adolescent. Based on this rating, adolescents were classified 
into 5 Tanner stages of pubertal development, with stage 1 corresponding to the prepubertal 
stage and stage 5 corresponding to the postpubertal stage24• Adolescents answered in the 
PDS questions about their physical development, including changes in growth, body hair, 
and skin changes (acne). Also, female subjects were asked about breast development and 
menstruation, and male subjects were asked about voice changes and growth of facial 
hair34. 
The PDS questionnaire results were recoded into 5 stages of pubertal development by 
using the algorithm developed by Carskadon and Acebo35 . By using this algorithm, female 
subjects without menarche and a total score of 5 or greater {body hair growth and breast 
development), male subjects with a total score of 4 to 5 and a 3-point response (body hair 
growth, voice changes and facial hair growth), and male subjects with a total score of 6 to 
8 and a 4-point response (body hair growth, voice changes and facial hair growth) were not 
recoded into a stage of pubertal development. Therefore in line with other studies, in our 
study female subjects with no menarche and a total score of 5 or greater were classified 
as midpubertal32 , and male subjects with a total score of 4 to 5 and a 3-point response and 
a total score of 6 to 8 and a 4-point response were classified as early and midpubertal, 
respectively. In the current study early pubertal was defined as stage 1, 2, or 3, whereas 
late pubertal was defined as stage 4 or 5. 
Statistical analysis 
Differences in continuous variables between groups were tested with the unpaired t test or 
the Mann-Whitney Utest, as appropriate. Differences in cell counts were tested with the X 2 
or Fisher exact tests. Changes in proportions between 2 surveys within groups were tested 
by using the McNemar test. Distributions were checked for normality by means of visual 
inspection of the probability plots of the residuals. Based on the literature, the following 
variables were entered into all models: BMI (normal weight, overweight, and obesity)25, birth 
weight36, and cigarette smoking during pregnancy37• Multiple logistic regression analysis was 
used to study the prevalence, incidence, and remission of asthma dependent on early versus 
late pubertal stage, as adjusted for potential confounders. Multiple linear regression analysis 
were used to study log-transformed total lgE levels and PEF fall during SRT dependent on 
early versus late pubertal stage, as adjusted for potential confounders. Both logistic and 
linear models were checked for multicollinearity. In none of the models was this a problem. 
Net changes in the prevalence of asthma over time (net result of incidence and remission) 
were estimated by using generalized estimating equations {GEE) models with age and age 
at first survey in the models. With GEE analysis, measurements of adolescents over time 
are analyzed, taking into account that these repeated measurements of 1 adolescent are not 
independent of each other. The relationship between pubertal stages and the development 
of asthma was analyzed separately for both the cross-sectional (between subjects at age 
11.1 years) and longitudinal (within a subject) associations. The regression coefficient of the 
cross-sectional analysis reflected the effect of pubertal stages on the prevalence of asthma 
at age 11 .1 years. The regression coefficient of the longitudinal analysis consisted of pooled 
analysis of both the cross-sectional and longitudinal effects of pubertal stages on asthma 
development. For all other variables, a pooled coefficient was given, consisting of both the 
cross-sectional and longitudinal (within-subject) components38• The association between 
Tanner stages (early vs late pubertal) and the prevalence of asthma was studied in the first 
and second survey. The association between PDS stages (early vs late pubertal) and the 
presence of asthma was studied at the second and third survey. Multiple logistic regression 
analysis, multiple linear regression analysis, and GEE analysis were performed in the total 
dataset and stratified according to gender given the aims of our study: assessing gender 
differences in (risk factors for) incidence and remission of asthma during transition through 
puberty. Statistical analysis were performed with SPSS 16.0 software (SPSS, Inc, Chicago, 
Ill). P-values of less than 0.05 (2-sided) were considered significant. 
RESULTS 
Study population 
A total of 2,230 adolescents with a mean ± SD age of 11.1 ± 0.6 years was included (51 % 
female subjects, Table 2.1). At the second survey, 96% (n=2,149) were reassessed (mean 
± SD age 13.6 ± 0.5 years; 51 % female subjects). Eighty-one percent of the original number 
(n=1,816) completed the third survey (mean ± SD age 16.3 ± 0.7 years; 52% female 
subjects) (Figure E2.1 in online supplement). Adolescents who completed the third survey 
were significantly more often female and had a significantly lower BMI compared with the 
baseline population (Table E2.1 in online supplement) . 
Asthma prevalence 
There was no significant difference in asthma prevalence between female and male 
subjects at 11.1, 13.6, or 16.3 years. In female subjects there was a significant difference 
in the prevalence of asthma between the ages of 11 .1 and 13.6 years but not between 
the ages of 11.1 and 16.3 years and 13.6 and 16.3 years. In male subjects there was a 
significant difference in the prevalence of asthma between the ages of 11.1 and 16.3 years 
and between the ages of 13.6 and 16.3 years but not between the ages of 11.1 and 13.6 
years (Figure 2.1 ) .  Twenty-one (43.8%) of 48 adolescents with asthma remission at 13.6 
years were still in remission, 9 (18.8%) reported having asthma again at 16.3 years, and for 
18 (37.5%) , information about asthma status at age 16.3 years was missing. 
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TABLE 2.1 I Population characteristics of the study population (n=2,230) 
Age (y) 11.1 ± 0.5 11.1 ± 0.6 
Tanner stage 1 327 (30.0) * 351 (34.3) 
Tanner stage 2 496 (45.5) * 619 (60.5) 
Tanner stage 3 203 ( 18.6) * 49 (4.8) 
Tanner stage 4 59 (5.4) * 2 (0.2) 
Tanner stage 5 6 (0.5) * 2 (0.2) 
Tanner stage 2 (1-5) * 2 (1-5) 
Asthma 77 (7.4) 77 (7. 7) 
BMI (kg/m2) 17.6 (12.7-33.9) * 17.1 (11.0-35.0) 
Normal weight 896 (81.5)* 920 (86.6) 
Overweight 166 (15.1)* 115 (10.8) 
Obesity 37 (3.4)* 27 (2.6) 
Birth weight (1 00g) 33.1 ± 6.1 * 34.7 ± 6.1 
Cigarette smoking during pregnancy 267 (33.6) 212 (30.0) 
Data are presented as number (percentage), mean ± SD or median (range). * p<0.05, significant 
difference between females and males. 
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FIGURE 2.1 I Prevalence, incidence, and remission of asthma. Dark column = prevalence. Gray 
column = incidence. Light column = remission. 
Pubertal stages 
At 11.1 years, 65 (5.9%) female and 4 (0.4%) male subjects were classified as late 
pubertal according to the Tanner stages. At the age of 13.6 years, 437 (51.4%) female 
and 91 (14.5%) male subjects were classified as late pubertal according to the Tanner 
stages, as well as 659 (65.4%) female and 121 (1 2.0%) male subjects according to the 
PDS questionnaire. At the age of 16.3 years, 851 (98.0%) female and 506 (65.5%) male 
subjects were classified as late pubertal according to the PDS questionnaire. At all ages, 
female subjects had significantly higher stages of pubertal development than male subjects. 
Information on both the Tanner stages and the PDS questionnaire was available for 1,403 
adolescents at the age of 13.6 years. 
Adolescents and parents agreed on classification as early pubertal 52% (726) of the time 
and agreed 27% (373) of the time about classification as late pubertal. Thus in 79% of the 
cases, there was agreement between adolescents and parents with respect to pubertal 
stages. The measurement of agreement (K) was 0.54 {p<0.001 ). 
Asthma and pubertal stages 
Complete data on gender, age, asthma, Tanner stage, BMI, birth weight, and cigarette 
smoking during pregnancy were available for 719 (63.5%) female and 632 {57.6%) male 
subjects at the age of 11.1 years and for 637 {56.3%) female and 444 (40.4%) male subjects 
at the age of 13.6 years. Complete data on gender, age, asthma, pubertal development 
stage, BMI, birth weight, and cigarette smoking during pregnancy were available for 679 
(60.0%) female and 636 {57.9%) male subjects at the age of 13.6 years and for 669 
(59.1 %) female and 586 (53.4%) male subjects at the age of 16.3 years. At the age of 
11 .1, 13.6, and 16.3 years, we observed no significant association between pubertal 
stages and asthma prevalence cross-sectionally in the total population or in female and 
male subjects separately. At the age of 13.6 and 16.3 years, we observed no significant 
association between pubertal stages and asthma incidence and remission cross-sectionally 
in the total population or in female and male subjects separately. A sensitivity analysis 
at the age of 13.6 years showed similar associations between parent-reported (Tanner) 
and adolescent-reported {PDS) pubertal stages and asthma. Restricting the analysis to 
the 1,099 adolescents for whom both the parents and the adolescent agreed on pubertal 
stages did not affect the effect estimates. In longitudinal analysis we found no significant 
association between the pubertal stage and asthma prevalence in female or male subjects 
(Table 2.2). A sensitivity analysis in which male subjects with a total score of 4 to 5 and a 
3-point response and male subjects with a total score of 6 to 8 and a 4-point response were 
recoded into midpubertal and late pubertal classifications, respectively, did not affect the 
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TABLE 2.2 I Independent longitudinal effect estimates of risk factors on the presence of asthma 
Age upon inclusion (y):t: 1.38 (0.81-2.35) 0.24 0.87 (0.48-1 .57) 0.64 1.14 (0.68-1.94) 
Longitudinal effect of time 1.00 (0.88-1.13) 0.95 0.98 (0.85-1.12) 0.74 0.98 (0.85-1.13) 
Pubertal stages§ 0.75 (0.44-1.27) 0.28 0.76 (0.21-2.78) 0.68 1 .00 (0.55-1.81) 
Obesity 3.25 (1.10-9.58) 0.03 0.56 (0.18-1.78) 0.33 4.01 (1.30-12.35) 
Overweight 2.01 (1.17-3.44) 0.01 1.59 (0.83-3.04) 0.17 2.44 (1.39-4.29) 
Birth weight (1 00g) 1.00 (0.96-1.04) 0.98 0.99 (0.94-1.04) 0.68 1.00 (0.96-1.04) 
Cigarette Smoking during 2.04 (1.15-3.60) 0.01 1 .30 (0.68-2.49) 0.43 1.70 (0.97-2.96) 
pregnancy 
0.62 0.92 (0.51-1.67) 0.79 
0.75 0.81 (0.68-0.97) 0.02 
0.99 1.42 (0.80-2.52) 0.23 
0.02 1.12 (0.15-8.66) 0.91 
<0.01 2.21 (1.20-4.07) 0.01 
0.85 1.00 (0.94-1.06) 0 .90 
0.06 1.18 (0.58-2.40) 0.66 
* Tanner stages. t PDS stages. + Reflects difference between longitudinal and cross-sectional effect of pubertal stages. § Defined as early versus late 
pubertal. 
effect estimates. Excluding age from the model did not affect the effect estimates. Excluding 
adolescents for whom BMI data were not available at all 3 surveys did not affect the effect 
estimates. 
Thirty-one percent (n=248) of the female subjects used OCs at the age of 16.3 years. There 
was no significant difference in BMI categories (normal weight, overweight, and obesity) 
between female subjects using OCs and those who did not use OCs. Controlling for OCs 
use did not change the association between pubertal stages and asthma. 
Total lgE 
The total median lgE level was 73.0 kU/L (25th-75th percentile, 24.6-224.0 kU/L). In the 
total population there was a near significant difference in total lgE levels between female 
and male subjects (p=0.052). Adolescents with asthma had significantly higher total lgE 
levels than adolescents without asthma. We did not find a significant association between 
pubertal stage and log-transformed total lgE levels in female or male subjects (Table E2.2 in 
online supplement). A sensitivity analysis in which male subjects with a total score of 4 to 5 
and a 3-point response and male subjects with a total score of 6 to 8 and a 4-point response 
were recoded into midpubertal and late pubertal classifications, respectively, did not affect 
the effect estimates. Excluding age from the model did not affect the effect estimates. 
PEF fall during SRT 
The median PEF before the SAT was 540 Umin (range (280-750 Umin)) in male subjects 
and 440 Umin (170-61 O Umin) in female subjects. The median PEF after the SAT was 550 
Umin (300-750 Umin) in male subjects and 450 Umin (190-630 Umin) in female subjects. 
Male subjects had significantly higher PEF values before and after the SAT {Table E2.3 in 
online supplement). Twenty-five percent of the population (total, 155; 88 female and 67 male 
subjects) had a fall in median PEF during the SAT of 20.0 Umin (10-140 Umin). PEF fall 
during the SAT was 20 Umin (10-140 Umin) in male subjects and 20 Umin (10-130 Umin) 
in female subjects. There was no significant difference in PEF fall during the SAT between 
female and male subjects (Table E2.3 in online supplement). Of the 155 adolescents with a 
PEF fall during the SAT, 11 (7%) adolescents had asthma, 132 {85%) did not have asthma, 
and 12 (8%) lacked information about asthma status at a mean age of 16.3 years. There 
was no significant difference in PEF fall during the SAT between adolescents with and 
without asthma. We found no significant association between PEF fall during the SAT with 
pubertal maturity in female or male subjects (Table E2.4 in online supplement). A sensitivity 
analysis in which male subjects with a total score of 4 to 5 and a 3-point response and male 
subjects with a total score of 6 to 8 and a 4-point response were recoded into midpubertal 
and late pubertal classifications, respectively, did not affect the effect estimates. Excluding 
age from the model did not affect the effect estimates. 
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DISCUSSION 
Our longitudinal study in a large group of boys and girls followed through puberty did not 
show differences in asthma prevalence between boys and girls at the age of 11.1 and 13.6 
years, whereas at 16.3 years of age, more female than male subjects had asthma. This 
higher prevalence of asthma at the age of 16.3 years was related to a higher incidence of 
asthma and lower remission of asthma in female compared with male subjects during this 
follow-up. This study did not show an association between pubertal stages and asthma 
prevalence. Additionally, we found no significant association between pubertal stages and 
asthma-related phenotypes (log-transformed total lgE levels and PEF fall during SRTs}. 
The strength of the current study is the longitudinal study design, which allowed us to 
study the association between pubertal stages and changes in asthma prevalence during 
transition through puberty. Adolescents were followed up from the age of 11.1 years until 
16.3 years. This is important because the mean age at which girls enter puberty is 10.5 
years, completing sexual development after 4.2 years on average, whereas boys enter 
puberty at 11 .5 years and achieve complete sexual development after 3.5 years on average3 • 
Our results are largely in agreement with findings from a previous study showing that in 
early childhood the prevalence of asthma is higher in boys than in girls1 0 • Between the 
ages of 9 and 11 years, the difference in the prevalence of asthma between boys and girls 
disappeared39. In agreement with these results, we found no difference in the prevalence 
of asthma between boys and girls at a mean age of 11.1 years. Nicolai et al3 followed-up 
adolescents with asthma from the age of 1 O years until 14 years. At 20 years of age, these 
adolescents were re-examined, together with a sample of nonasthmatic adolescents from 
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asthma than female subjects in the initially studied group. However, in the group without 
asthma at the age of 1 O years, twice as many female subjects had asthma at age 20 years4 , 
indicating a higher incidence of asthma in female compared with male subjects between 
the ages of 1 O and 20 years. This is in agreement with our data, in which the incidence 
of asthma was higher and remission was lower in female compared with male subjects 
between the ages of 13.6 and 16.3 years. 
We are the first to study the association between pubertal stages and the net change in the 
prevalence of asthma over time (net result of incidence and remission) using longitudinal 
methods. Despite the fact that we identified the hypothesized gender switch in the prevalence 
of asthma, we observed no association between pubertal stages and asthma prevalence. 
In addition, we found no significant associations between pubertal stages and asthma­
related phenotypes, such as log-transformed total lgE levels or PEF fall during SRTs at the 
age of 16.3 years. As far as we know, only 1 previous study has directly related pubertal 
stages to asthma, but this study of Nicolai et al3 included asthmatic subjects only and their 
prognosis. In this study menarche, voice changes, and serum androstanediol glucuronide 
levels (an endocrine marker that reflects peripheral testosterone metabolism) were used 
as a surrogate for late puberty. In accordance with the results of our study, Nicolai et al3 
found no statistically significant relationship between the reported signs of late puberty and 
remission of asthma in adolescents who had had active asthma at age 1 O years. Likewise, 
no association was found between androstanediol glucuronide levels and asthma3• 
There is a randomized, double-blind, multicenter clinical trial that investigated the relationship 
between airway responsiveness and pubertal stages40• This study consisted of a treatment 
phase (budesonide, 400 µg daily, or nedocromil sodium, 1 6  mg daily) and an observation 
phase (with asthma care based on national guidelines). Children aged 5 to 1 2  years with 
mild-to-moderate asthma were followed up 8.6 ± 1 .8 years, and methacholine provocation 
tests were performed before randomization, 8 months after randomization, and then yearly. 
They found that between the ages of 5 and 1 1  years, PC20 values increased in both girls 
and boys. However, after the age of 1 1  years, PC20 values continued to increase in boys 
compared with the minimal increase seen in girls. This increase in PC20 values in boys 
relative to girls started at Tanner stage 2. The mean age at which children enter Tanner 
stage 2 is 1 1  years. The results of this study are not consistent with our results, namely no 
association between pubertal stages and asthma. Possible explanations for this inconsistent 
finding could be the fact that our study was a population-based study, and in the study of 
Tantisira et al40, children with mild-to-moderate asthma were included. Second, Tantisira et 
al studied airway responsiveness, whereas we studies exercise-induced asthma. Third, in 
the study of Tantisira et al , assessment of pubertal stages was done by a physician. We 
used both parent-reported and adolescent-reported pubertal development. 
The suggestion that hormonal changes, as occur during puberty, play a role in asthma 
development and remission5•8·1 0•1 4•15•19•20 was not confirmed by our study. We used 
questionnaires as proxy measures of what is really happening during puberty (ie, changes 
in sex hormones) . However, questionnaires might be too insensitive to reflect hormonal 
changes. 
If the gender switch in the prevalence of asthma is not due to changing levels of sex 
hormones, the question arises of which other mechanisms could potentially explain this 
development. One potential mechanism is the difference in physical growth of the lungs 
from birth into adulthood between boys and girls. At birth, boys have narrower airways in 
proportion to total lung volume than girls. The development of the lungs continues until 
adolescence41 , when a difference in maturation of the airways in comparison with lung 
parenchyma and airspace exists between female and male subjects1 0• This leads to a 
smaller airway diameter in relation to lung volume in female compared with male subjects 
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at the age of 16 years10• 1 6 • This gender difference in lung growth could explain why male 
subjects are at risk for asthma early in life but female subjects are at risk especially after 
puberty. However, there is also evidence that a smaller airway size does not simply lead to 
a higher risk of asthma because, especially in children, there is not much difference in the 
absolute size of the airways between boys and girls 1°. 
A second potential mechanism to explain the gender switch in the prevalence of asthma 
occurring during puberty is obesity, a recognized risk factor for the development of asthma25 • 
Obesity is accompanied by an increased production of estrogens and is therefore related 
to the development of puberty in a gender specific way. Obesity is associated with early 
menarche in girls and a delayed puberty in boys42• Obese girls with early menarche (before 
the age of 11 years) have a higher risk of asthma than those with late-onset menarche42•43• 
Both in cross-sectional and longitudinal analysis, we identified obesity as a risk factor for 
asthma in female subjects. For male subjects, we found no association between obesity 
and asthma both in cross-sectional and longitudinal analysis. These findings could indicate 
a positive role for BMI in the development of asthma in female subjects. However, the 
difference in BMI development during transition through puberty could not explain the 
observed sex-related switch in asthma prevalence because of the fact that boys and girls 
had the same increase in BMI during transition through puberty. 
C\J Our study has some limitations. In the current study puberty was assessed by using 2 
� different questionnaires, one filled in by the parents at the first (mean age, 11.1 years) 
� 
(3 and second (mean age, 13.6 years) surveys (Tanner) , and the other (PDS) filled in by 
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the adolescents at the second (mean age, 13.6 years) and third (mean age, 16.3 years) 
surveys. The fact that we analyzed the data for the Tanner stages and PDS questionnaire 
separately decreased the power to detect a significant association between pubertal stages 
and asthma prevalence and resulted in large Cls for the estimated odds ratios. 
The second limitation was that asthma was defined as having a parentally reported 
physician's diagnosis of asthma and/or having symptoms of asthma and/or use of asthma 
treatment prescribed by a physician in the past 12 months. Based on our data, we cannot 
determine whether children had just exercise-induced asthma in isolation or transient 
wheeze related to a respiratory tract infection or more established asthma. We know 
from (unpublished) data of the Dutch part of the European Community Respiratory Health 
Survey that in the general population 98% of the subjects who report asthma indeed have 
a physician's diagnosis of asthma. Therefore we believe that using questionnaire data to 
define asthma status is a reliable way to determine the presence of asthma in a Dutch 
general population-based cohort like TRAILS. 
One advantage of the longitudinal study design used in this study is the fact that both 
the cross-sectional and longitudinal effects of pubertal stages on the development of 
asthma could be analyzed. However, at the age of 11.1 years, 99.6% (1,019) of the boys 
were classified as early pubertal, and therefore analyzing both the longitudinal and cross­
sectional effects of the Tanner stages on the development of asthma was not possible. At 
the age of 13.6 years, 12.0% (121) of the male subjects were classified as late pubertal. 
At this age, we could study both the cross-sectional and longitudinal effects of the PDS 
stages on the development of asthma between the ages of 13.6 and 16.3 years. We found 
no significant association between the cross-sectionally and longitudinally analyzed PDS 
stages and asthma development (data not shown). 
In summary, our longitudinal study shows that a shift in asthma prevalence has already 
started at the age of 11.1 years and goes on until 16.3 years. This shift is due to both 
a higher incidence of asthma and a lower remission of asthma in female compared with 
male subjects during this pubertal period. This shift cannot simply be explained by changes 
in pubertal stages. At the age of 16.3 years, no association was found between pubertal 
stages and asthma-related phenotypes (log-transformed total lgE levels and PEF fall during 
SRTs). We found no association between the sex switch in asthma and pubertal stage, 
and therefore questionnaires (Tanner and PDS) to assess pubertal stage might be too 
insensitive to estimate hormonal changes. More studies, using even smaller time intervals 
and measuring actual levels of sex hormones, are needed to disentangle the role of sex 
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TABLE E2.1 I Comparison of baseline characteristics between adolescents who completed the 







Birth weight (100 g) 
Follow-up Lost to follow-up 
n = 1 ,816 n = 414 
950 (52.3)* 1 82 (44.0) 
866 (47.7)* 232 (56.0) 
11.1 ± 0.6 11.1 ± 0.5 
2 (1-5) 2 (1-5) 
124 (7.3) 30 (8.6) 
17.3 (11.0-35.0)* 17.7 (12.8-31.6) 
33.9 ± 6.1 33.8 ± 6.3 
Cigarette smoking during pregnancy 479 (31.9) NA 
Data are presented as number (percentage), mean ± SD or median (range). NA= Not assessed. 
*p<0.05, significant difference between follow-up and lost to follow-up. §Defined as early versus 
late pubertal. 
TABLE E2.2 I 1ndependent cross-sectional associations of risk factors for serum log transformation 
of total lgE levels in female and male subjects at the age of 16.3 years 
· · 
Female subjects Male subjects 
. � (95% Cl) p-val�e b (95% Cl) p-value 
Age (y) -0.04 (-0.13-0.06) 0.34 0.01 (-0.09-0.11) 0. 86 
Pubertal stage* -0.20 (-0.59-0.20) 0.33 0.05 (-0.08-0.18) 0.44 
Obesity 0.29 (-0.09-0.67) 0.14 0.28 (-0.09-0.65) 0.13 
Overweight 0.06 (-0.13-0.24) 0.52 -0.01 (-0.22-0.20) 0.94 
Birth weight (100 g) 0.01 (-0.00-0.02) 0.09 0.00 (-0.01-0.01) 0.63 
Cigarette smoking 0.04 (-0.09-0.17) 0.54 -0.18 (-0.32- -0.05) 0.01 
during pregnancy 
b = regression coefficient. *Defined as early versus late pubertal. 
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TABLE E2.3 I SRT 






PEF after SRT (Umin) 450 (190-630)* 
PEF fall during SRT (%) 20 (10-130) 
*Values are expressed as median (range). 
TABLE E2.4 I Independent cross-sectional associations of risk factors for percentage fall in PEF 
after SRT in female and male subjects at the age of 16.3 years 
Age (y) -0.48 (-2.53-1.57) 0.65 0.61 (-1.25-2.46) 0.52 
Pubertal stage* 1.86 (-4.04-7.76) 0.54 1.70 (-0.34-3.73) 0.10 
Obesity 2.36 (-6.40-11.11) 0.60 -7.88 (-15.22- -0.53) 0.04 
Overweight 0.43 (-3.47-4.33) 0.83 -3.42 (-6.85-0.01) 0.05 
Birth weight (100 g) -0.23 (-0.41- -0.06) 0.01 -0.19 (-0.35- -0.03) 0.02 
Cigarette smoking 0.44 (-1.91-2.78) 0.71 0.54 (-1.66-2.74) 0.63 
during pregnancy 
b = regression coefficient. *Defined as early versus late pubertal. 









Did your child have asthma symptoms during the last 12 months? 
Did your child use asthma medication during the last 12 months? 
Was your child treated for asthma by a physician during the last 12 
months? 
Did a physician give your child a diagnosis of asthma? 
Did the mother smoke any cigarettes during the first trimester of 
pregnancy? 
Did the mother smoke any cigarettes during the second trimester of 
pregnancy? 
Did the mother smoke any cigarettes during the third trimester of 
pregnancy? 
What was your child's birth weight? 
*Cigarette smoking during pregnancy. 
Survey (mean age) 
Survey 1 (1 1 . 1 years) 
2,230 Adolescents 
l-
Survey 2 (13.6 years) 
2, 149 Adolescents 
l 
Survey 3 (16.3 years) 
1 ,8 16  Adolescents 
Lost to follow-up: 
81 Adolescents 
Lost to follow-up: 
333 Adolescents 
Included in analysis 
1 ,351 adolescents* 
l 1 ,263 adolescents 
1 ,354 adolescents# 
l 1 ,  1 71 adolescents 
1 ,255 adolescents,i 
FIGURE E2.1 I Overview of adolescents included in the study. 









Background: Genes involved in allergy (/L4, IL4R and IL 13) ,  epithelial function (CDH1 and 
PCDH1) and airway remodeling (ADAM33) are associated with asthma. Combining these 
genes with modest effects on asthma into a genetic risk score (GRS) might result in a better 
prediction of asthma development. We studied (1 ) the predictive properties of the GRS for 
asthma development, and (2) the interaction between G RS and common risk factors. 
Methods: We studied adolescents from the TRacking Adolescents' Individual Lives Survey 
(TRAILS) study (n=2,230, age surveys 1 =1 1 years, 2=1 4  years, 3=1 6 years) using logistic 
regression models adjusted for sex. G RS was calculated by summing the number of risk­
raising al leles. 
Results: GRS was significantly associated with asthma (OR {95% Cl) 1 .1 9  (1 .03-1 .36)), as 
were common risk factors such as in utero exposure to maternal smoking (1 .64 (1 . 1 5-2.33)) 
and maternal asthma (4.61 (2.95-7. 1 9)). Moreover, GRS remained significantly associated 
with asthma (1 .25 (1 .06-1 .47)) after adjustment for these common risk factors. There was 
no significant interaction between GRS and the common risk factors. 
Conclusion: The GRS is a highly significant independent predictor of asthma. Its merits 
should be further explored on its potential in clinical and screening practice. 
INTRODUCTION 
Asthma is a complex disease, in which multiple genes in biological pathways are involved, 
for instance genes in pathways of T helper 2 (Th2) cell differentiation and allergic 
inflammation like interleukin 4 (IL4) , IL4 receptor (/L4R) and interleukin 13 (/L 13)) , epithelial 
function (E-cadherin (CDH1) and Protocadherin-1 (PCDH1)) and airway remodeling (A 
Disintegrin And Metalloprotease 33 (ADAM33)).  Several single nucleotide polymorphisms 
(SNPs) in these genes have been linked to the susceptibility for development of asthma and 
asthma-related phenotypes1 -1 1 • However, the effects of these individual SNPs on asthma or 
asthma-related phenotypes are modest. Therefore, combining the effect of SNPs in these 
multiple genes into a genetic risk score (GRS) might result in a better predictor of asthma 
development. 
Other risk factors that are known to be associated with an increased risk for asthma 
development are in utero exposure to maternal smoking and maternal asthma1 2•13• Moreover, 
recent studies showed an interaction between in utero exposure to passive smoking and 
IL 13, PCDH1 and ADAM33 resulting in an increased risk of early onset persistent wheeze 14, 
lung function decline15  and in the development of bronchial hyperresponsiveness (BHR)8•1 6, 
al l asthma-related phenotypes. However, it is yet unknown whether these gene-environment 
interactions also play a role in asthma development in adolescence. In addition, the effect 
of the interaction between maternal asthma and genetic predisposition on asthma is also 
largely unknown. 
We constructed a GRS based on SNP in genes that were reported to be significantly 
associated with asthma and asthma-related phenotypes in the literature, i.e. IL4, IL4R, IL 13, 
CDH1, PCDH1 and ADAM33. We tested the predictive properties of this GRS for asthma 
development in the TRAILS cohort of adolescents. We compared this predictive value of 
the GRS with common risk factors for asthma development, i .e. in utero smoke exposure 
to maternal smoking and maternal asthma. Additionally, we studied whether there were 
interactions of the GRS with these common risk factors on asthma development. 
METHODS 
Study population and design 
We studied subjects from the TRacking Adolescents' Individual Lives Survey (TRAILS). 
TRAILS is a prospective cohort study among Dutch adolescents. The TRAILS cohort is 
a representative sample of adolescents of the general population. So far, three surveys 
have been completed: survey 1 in 2001-2002 (n=2,230, mean ± SD age 11 ± 0.6 years), 
survey 2 in 2003-2004 (n=2, 149, mean ± SD age 14 ± 0.5 years) and survey 3 in 2005-
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2007 (n=1,816, mean ± SD age 16 ± 0.7 years). Adolescents will be followed until at least 
the age of 24 years. Detailed information about the sample selection and study design has 
been described elsewhere17 • 
Asthma 
Information about parentally reported asthma (doctor diagnosis of asthma, symptoms 
of asthma and asthma treatment prescribed by a physician in the past 12 months) was 
collected at age mean age 11, 14 and 16 years of the adolescents using questionnaires18 • 
Asthma was defined as parentally reported doctor diagnosis of asthma, and/or symptoms 
of asthma and/or asthma treatment prescribed by a physician in the past 12 months at age 
mean age 11, 14 and/or 16 years18 . 
Early environmental risk factors for asthma development 
Information on parentally reported in utero exposure to maternal smoking was collected 
at mean age 16 years using a standardized questionnaire18 . Information about parentally 
reported maternal asthma was reported at age mean age 11 years. 
Selection of SNPs 
Genes implicated in Th2 cell differentiation and allergic inflammation (IL4, IL4R and 
IL 13), epithelial function (CDH1 and PCDH1) and airway remodeling (ADAM33) that were 
previously found to be significantly associated with asthma or asthma-related phenotypes1 •1 1  
were used to construct the GRS. (t)SNPs in these genes were selected using Haploview. A 
total of 10 SNPs were included into the GRS calculation. (See on line supplement for detailed 
information about the selected SNPs for IL4, IL4R, IL 13, CDH1, PCDH1 and ADAM33). 
Genotyping 
At mean age 16 years (n=1,816), DNA was extracted from blood samples (n=1,207) or 
buccal swabs (Cytobrush®, n=258) using a manual salting out procedure as described 
by Miller and colleagues19• SNP typing was performed on the Golden Gate lllumina 
BeadStation 500 platform (lllumina, Inc., San Diego, CA, USA) following the manufacturer's 
protocol. Genotype clustering was performed in BeadStudio 3.0. (lllumina, Inc., San Diego, 
CA, USA). SNPs were genotyped in 1,454 adolescents. See online supplement for detailed 
information about genotyping and quality control. 
Statistical analysis 
To study the predictive properties of the combined effect of SNPs in IL4, IL4R, IL 13, CDH1, 
PCDH1 and ADAM33 on asthma, a GRS was calculated. Firstly, the individual SNPs in IL4, 
IL4R, IL 13, CDH1, PCDH1 and ADAM33 were analyzed in an additive genetic model for the 
effect on asthma using logistic regression models adjusted for sex. 
Secondly, SNPs that were associated with asthma within the TRAILS study (p �0.20; 
rs762534 (/L4), rs3024578, rs3024647, rs12102586 (/L4R), rs3091307, rs2243297 (/L 13), 
rs12447341, rs13689, rs8061932 (CDH1), rs14359, rs3822357, rs11167761, rs17097812 
(PCDH1), rs3918396 (ADAM33J, Table 3.2) were included in the GRS. The risk-raising 
allele was defined as the allele that is associated with a higher risk of asthma (homozygote 
non-risk genotype = 0, heterozygote and homozygote risk genotype = 1 ). Since for rs762534 
( IL4), rs3024578, rs12102586 ( IL4R) and rs2243297 ( IL 13) only the heterozygote and not 
the homozygote genotypes were associated with a higher risk of asthma, these SNPs 
were not included into the calculation of the GRS. GRS was calculated by summing the 
number of risk-raising alleles. A logistic regression model was used to study the association 
between GRS and asthma development adjusted for sex. Next, logistic regression models 
were used to study the associations between early environmental risk factors (e.g. in utero 
exposure to maternal smoking and maternal asthma) and asthma development adjusted 
for sex. Furthermore, logistic regression model was used to study the association between 
GRS and asthma development after adjustment for sex and the common risk factors in 
utero exposure to maternal smoking and maternal asthma. 
Thirdly, we tested whether there was interaction between the GRS and in utero exposure to 
maternal smoking on the development of asthma by performing logistic regression analysis 
with GRS, in utero exposure to maternal smoking and the interaction term GRS x in utero 
exposure to maternal smoking into the model, adjusted for sex. Using a similar model, we 
tested whether there was interaction between the GRS and maternal asthma. 
Statistical analysis were performed using SPSS Inc. Windows 18.0. P-values<0.05 (tested 
2-sided) were considered to be significant. 
RESULTS 
Characteristics of the study population 
Table 3.1 shows the characteristics of the study population. The SNPs selected form IL4, 
IL4R, IL 13, CDH1, PCDH1, ADAM33 and their association with asthma development are 
shown in Table 3.2. There were no differences between adolescents whose DNA was or 
was not available for genotyping with regard to asthma development, in utero exposure to 
maternal smoking or maternal asthma. However, adolescents whose DNA was available 
for genotyping were more often females compared to adolescents whose DNA was not 
available for genotyping. 
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TABLE 3.1 I Characteristics of the study population 
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Females 1,132 (51) 
Ever Asthma 209 (10) 
Asthma at mean age 11 years 154 (8) 
Asthma at mean age 14 years 112 (6) 
Asthma at mean age 16 years 79 (5) 
In utero exposure to smoking 479 (32) 
First trimester 462 (31) 
Second trimester 407 (27) 
Third trimester 402 (27) 
Maternal asthma 1 109 (6) 
Data are presented as number (percentage of non-missing values) . 1 At baseline (mean age 11 
yrs). 
Association of the predictive properties of GRS, in utero exposure to maternal 
smoking and maternal asthma with asthma development 
Table 3.3 shows the estimated effects of G RS, in utero exposure to maternal smoking and 
maternal asthma on asthma development adjusted for sex. The GAS, in utero exposure 
to maternal smoking and maternal asthma were al l  significantly and positively associated 
with asthma development. After adjustment for in utero exposure to maternal smoking and 
maternal asthma, the GAS was still significantly and positively associated with asthma 
development. 
Interaction of the GRS with in utero exposure to maternal smoking and maternal 
asthma 
Table 3.4 shows the estimated interaction effect between GAS and the common risk factors 
on asthma development. There was no significant interaction between the GAS and in utero 
exposure to maternal smoking. There was also no significant interaction between the GAS 
and maternal asthma. 
TABLE 3.2 1 Estimated associations between single nucleotide polymorphisms (SNPs) in /L4, IL4R, IL 13, CDH1, PCDH1, ADAM33 and asthma in the 
TAAi Ls cohort 
rs number Gene Chromosome Major > Minor allele MAF Frequency OR (95% Cl)1 p-value 
rs2243266 /L4 5 
rs2227282 IL4 5 
rs2243248 /L4 5 
rs762534 IL4 5 
rs2243263 IL4 5 
rs3024578 IL4R 1 6  
rs3024544 /L4R 1 6  
rs3024530 IL4R 1 6  
rs649801 1 IL4R 1 6  
rs3024647 IL4R 1 6  
rs3024676 IL4R 1 6  
rs1 029489 IL4R 1 6  
rs8832 IL4R 1 6  
rs2239347 IL4R 1 6  
rs4787956 IL4R 1 6  
rs8057585 IL4R 1 6  
rs4787948 IL4R 1 6  
rs3024622 IL4R 1 6  
rs1 21 02586 IL4R 1 6  
rs302461 3  IL4R 1 6  
rs3024585 IL4R 1 6  
GIG 27 1 ,454 1 . 1 6  (0.83-1 .63) 
CIC 8 1 ,453 1 .08 (0.82-1 .42) 
A/C 9 1 ,454 0.96 (0.60-1 .52) 
CIA 1 2  1 ,454 0.65 (0.39-1 .07)* 
CIG 27 1 ,454 0.82 (0.55-1 .23) 
GIA 8 1 ,454 0.71 (0.42-1 . 1 8)* 
GIA 1 5  1 ,454 0.85 (0.60-1 .22) 
A/G 47 1 ,452 0.92 (0.72-1 . 1 8) 
GIA 40 1 ,454 1 .04 (0.81 -1 .33) 
A/G 1 5  1 ,454 0.74 (0.50-1 .08)* 
CIA 1 7  1 ,454 1 .06 (0.76-1 .48) 
GIA 44 1 ,454 0.94 (0. 7 4-1 .20) 
GIA 50 1 ,453 1 .02 (0.80-0.30) 
A/C 47 1 ,453 0.88 (0.68-1 . 1 2) 
A/G 40 1 ,454 1 .01 (0. 78-1 .29) 
GIC 42 1 ,454 0.90 (0.70-1 . 1 6) 
A/G 31 1 ,454 1 .04 (0.81 -1 .35) 
GIC 37 1 ,453 0.99 (0.76-1 .29) 
GIA 9 1 ,454 0.70 (0.43-1 . 1 4)* 
GIA 47 1 ,346 1 . 1 5  (0.90-1 .4 7) 
GIA 49 1 ,430 0.96 (0.74-1 .24) 
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TABLE 3.2 I Continued 
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rs2057768 IL4R 16 GIA 29 1,454 0 .98 (0.75-1.29) 0.89 
rs3024560 IL4R 16 A/C 37 1,452 1.01 (0.78-1.32) 0.92 
rs1295685 IL 13 5 GIA 21 1,454 1.00 (0.74-1.35) 1.00 
rs2243208 IL 13 5 A/G 10 1,454 0 .83 (0.54-1.27) 0.38 
rs3091307 IL 13 5 A/G 21 1,453 0 .77 (0.56-1.06)* 0.11 
rs1295683 IL 13 5 GIA 11 1 ,452 1.21 (0.84-1.74) 0.31 
rs2243297 IL 13 5 A/T 4 1,443 0.55 (0.24-1.26)* 0.15 
rs9929218 CDH1 16 GIA 22 1,454 0.99 (0. 75-1.30) 0.94 
rs11640099 CDH1 16 A/C 13 1,454 1.07 (0.76-1.52) 0.69 
rs12447341 CDH1 16 GIA 35 1 ,454 0.75 (0.57-0.98)* 0.03 
rs13689 CDH1 16 A/G 22 1 ,454 1.26 (0 .95-1.66)* 0.11 
rs8061932 CDH1 16 A/G 16 1,454 1.23 (0.91-1.68)* 0.18 
rs10431924 CDH1 16 GIA 41 1 ,439 1.11 (0.87-1.42) 0.41 
rs9927789 CDH1 16 A/C 11 1,451 1.06 (0.72-1.58) 0.76 
rs2276329 CDH1 1 6  A/G 9 1,451 1.11 (0.73-1.69) 0.62 
rs3931740 CDH1 16 CIA 9 1,453 0.97 (0.63-1.49) 0.88 
rs7188750 CDH1 16 GIA 18 1,453 1.19 (0.88-1.61) 0.26 
rs47853573 CDH1 16 A/G 34 1,450 0.89 (0.69-1.16) 0.38 
rs2276330 CDH1 16 A/G 15 1,451 1.23 (0.88-1.72) 0.22 
rs11075699 CDH1 16 A/G 45 1,451 0 .93 (0.72-1.19) 0.55 
rs7186053 CDH1 1 6  G/A 4 1  1 ,451 1 .1 2  (0.88-1 .44) 0.36 
rs1 6958383 CDH1 1 6  G/A 1 6  1 ,454 1 . 1 9  (0.87-1 .62) 0.28 
rs6888 135 PCDH1 5 A/C 50 1 ,452 0.96 (0. 75-1 .23) 0.73 
rs1 4359 PCDH1 5 G/C 23 1 ,453 1 .27 (0.96-1 .66)* 0.09 
rs43821 96 PCDH1 5 C/G 46 1 ,453 0 .93 (0.72-1 . 1 9) 0.56 
rs3822357 PCDH1 5 G/A 8 1 ,452 0.58 (0.33-1 .00)* 0.051 
rs1 00541 86 PCDH1 5 G/C 1 8  1 ,454 0.89 (0.64-1 .23) 0.48 
rs1 0063472 PCDH1 5 G/A 20 1 ,453 0.94 (0.68-1 .28) 0.68 
rs771 9391 PCDH1 5 G/C 31 1 ,452 0 .93 (0.71 -1 .21 ) 0.58 
rs1 1 1 67761 PCDH1 5 G/A 1 8  1 ,454 0.80 (0.57-1 . 1 2)* 0. 1 9  
rs1 70978 1 2  PCDH1 5 G/A 1 1  1 ,454 0.71 (0.46-1 . 1 1 )* 0. 1 3  
rs391 8396 ADAM33 20 G/A 9 1 ,453 1 .32 (0.90-1 .94)* 0. 1 5  
rs597980 ADAM33 20 G/A 25 1 ,453 1 .1 1  (0.87-1 .42) 0.41 
rs2787094 ADAM33 20 G/C 25 1 ,452 1 .08 (0.82-1 .42) 0.59 
MAF = minor allele frequency. 1 Adjusted for sex. IL4 = interleukin 4. IL4R = interleukin 4 receptor. IL 13 = interleukin 1 3. CDH1 = E-cadherin. PCDH1 = 
Protocadherin- 1 . ADAM33 = A Disintegrin And Metalloproteinase Domain 33. * p � 0.20. Bold p<0.05. 
� A genetic risk score predicting asthma development 
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TABLE 3.3 I Estimated associations between respectively the G RS, in utero exposure to 
maternal smoking and maternal asthma and asthma development. 








1.64 (1.15-2.33)* NA 1.86 (1.23-2.80)* 
NA 4.61 (2.95-7.19)* 4.63 (2.54-8.44)* 
1 At baseline (mean age 11 yrs). GRS = genetic risk score (rs3024647 (/L4R), rs3091307 (IL 13), 
rs12447341, rs13689, rs8061932 (CDH1), rs14359, rs3822357, rs11167761, rs17097812 
(PCDH1), rs3918396 (ADAM33)) .  NA = not applicable. * p<0.05. 
TABLE 3.4 I Estimated interaction effect between GRS and common risk factors for asthma 
development i.e. in utero exposure to maternal smoking respectively maternal asthma, on 
asthma development 
GRS 1.25 (1.02-1.53)* 1.18 (1.00-1.38)* 
In utero exposure to smoking 2.66 (0.27-26. 72) NA 
GRS* in utero exposure to smoking 0.94 (0.69-1.29) NA 
Maternal asthma1 NA 1 .02 (0.04-24.28) 
GRS*maternal asthma1 NA 1 .23 (0.78-1 .88) 
1 At baseline (mean age 11 yrs). GRS = genetic risk score (rs3024647 (/L4R), rs3091307 (IL 13), 
rs12447341, rs13689, rs8061932 (CDH1), rs14359, rs3822357, rs11167761, rs17097812 
(PCDH1), rs3918396 (ADAM33)) . NA= not applicable. *p<0.05. 
DISCUSSION 
This study showed that a GAS based on the combined effect of SNPs in genes associated 
with Th2 cell differentiation and allergic inflammation, epithelial function and airway 
remodeling, is a highly significant independent predictor of asthma development. The 
predictive properties of the GAS were independent of the other risk factors, i.e. in utero 
exposure to maternal smoking and maternal asthma. 
A single SNP in a single gene can only explain a small part of the variance in asthma 
prevalence. Therefore, combining these genes with modest effects into a genetic risk score 
(GAS) might result in a better prediction of asthma development. To our knowledge there 
are no previous studies that investigated the combined effect of IL4R, IL 13, CDH1, PCDH1 
and ADAM33 by constructing a GAS for asthma. We found that the GAS was associated 
with an increased risk to develop asthma, even after adjustment for well known risk factors 
for asthma development. 
Not only genes, but also environmental factors and gene-environmental interactions are 
known to be involved in asthma development. Our study confirms previous studies showing 
that in utero exposure to maternal smoking is a risk factor for asthma development12•1 3• 
Exemplary, recent studies have shown in utero exposure to passive smoking seems to 
interact with IL 13, PCDH1 and ADAM33, resulting in an increased risk of early-onset 
persistent wheeze, excess lung function decline14 and in the development of bronchial 
hyperresponsiveness14-16• However, our study suggests that the increased risk on asthma 
associated with a higher GAS was not dependent on in utero exposure to maternal smoking, 
since we observed no interaction between both on the risk of asthma development. Likewise, 
our study confirms results of previous studies that showed maternal asthma is a common 67 
risk factor for asthma development1 6, and that there was no interaction between GAS and 
maternal asthma. However, since this is the first study investigating these interactions, 
further studies are needed to confirm our findings. 
Our study shows that independent of common risk factors for asthma development (i.e. 
in utero exposure to maternal smoking and maternal asthma), our GAS is predictive for 
asthma development in adolescence. The question arises whether our current GAS is a 
better identifier of individuals at risk for asthma development compared to the common risk 
factors for asthma development that are easy to obtain and less expensive. To solve this 
question we compared the area under the receiver operating characteristic curve (AUG) to 
see which risk factor(s) would indentify best those individuals with asthma. Comparison of 
the AUCs revealed that the discriminative power to detect adolescents at risk for asthma 
was comparable for in utero exposure to maternal smoking, maternal asthma and GAS. 
Moreover, the discriminative power increased when information about in utero exposure to 
maternal smoking and maternal history of asthma were combined. However, additionally 
adding GRS to this model did not clin ically improve this discriminative power (Table E3. 1  
i n  online supplement) . Although the discriminative power of our current GAS to detect 
adolescents at risk for asthma is comparable to common risk factors for asthma that are 
easier to obtain and less expensive, the GAS sti l l  is a useful tool since our study showed 
that the GAS is a h ighly significant independent predictor of asthma, even when in utero 
exposure to maternal smoking and maternal asthma are taken into account (Table 3.3) . 
Moreover, knowledge of genetic background is necessary for unraveling (genetic) pathways 
underlying asthma development to reveal its etiology. I n  addition, by knowing these 
pathways one could start interventions to prevent asthma and develop medication to treat 
asthma exacerbations. 
A strength of our study is its longitudinal design, allowing us to study asthma development 
using the GAS. Our study also has some limitations. There are more risk increasing genes 
for asthma development than only those belonging to the pathways selected in this study. 
In addition, there are also genetic variants in genes that seem to have a protective effect for 
the development of asthma. It would be of interest to test whether including SNPs of these 
genes improve the predictive value of GAS for asthma development. 
In conclusion, the GAS can be used as a tool to predict development of asthma independent 
of common risk factors for asthma development such as in utero exposure to maternal 
� smoking and maternal asthma. Its merits should be further explored on its potential in 





Selection of SNPs 
SNPs within genes associated with T helper 2 (Th2) cell differentiation and allergic 
inflammation (/L4: rs2243266, rs2227282, rs2243248, rs762534, rs2243263; IL4R: 
rs3024578, rs3024544, rs3024530, rs1 80501 2, rs1 80501 3, rs649801 1 ,  rs3024647, 
rs1 1 1 0470, rs3024676, rs8832, rs2239347, rs1 801 275, rs2283563, rs4787956, rs8057585, 
rs4787948, rs3024622, rs1 2 1 02586, rs302461 3, rs3024585, rs2074570, rs2057768, 
rs3024560, rs 1 029489 and IL 13: rs 1 295685, rs2243208, rs3091 307, rs 1 295683, rs2243297), 
epithelial function (CDH1: rs992921 8, rs1 1 640099, rs1 1 25557, rs1 2447341 , rs1 3689, 
rs8061 932, rs1 0431 924, rs9927789, rs20 1 1 779, rs1 1 6461 58, rs1 25971 88, rs2276329, 
rs3931 740, rs8056633, rs71 88750, rs4783573, rs2276330, rs1 1 075699, rs 7203904, 
rs71 86053, rs1 6958383 and PCDH1: rs68881 35, rs1 4359, rs3935792, rs43821 96, 
rs1 251 5587, rs3822357, rs1 00541 86, rs1 0063472, rs771 9391 , rs1 1 1 67761 , rs1 709781 2) 
and airway remodeling (ADAM33: rs391 8396, rs528557, rs597980, rs2787094, rsS 1 1 898, 
rs61 2709, rs2280089) were selected based on previously shown associations with asthma 
in other studies1•1 1 or tagging SNPs using Haploview. 
Genotyping 
At mean age 1 6  years (n=1 ,81 6), DNA was extracted from blood samples (n= 1 ,207) or 
buccal swabs (Cytobrush®, n=258) using a manual salting out procedure as described 
byMiller and colleagues19• SNP typing was performed on the Golden Gate l l lumina 
BeadStation 500 platform (lllumina, Inc . ,  San Diego, CA, USA) following the manufacturer's 
protocol. Genotype clustering was performed in BeadStudio 3.0 (l llumina, Inc. ,  San Diego, 
CA, USA) . Of 1 ,454 adolescents, SNPs were genotyped. 
Genotyping of rs1 1 1 0470 (/L4R), rs1 1 25557, rs1 1 6461 58 (CDH1) and rs51 1 898, rs61 2709, 
rs2280089 (ADAM33) and failed and were replaced by rs2040789 (IL4R), rs1 2448999, 
rs4783689 (CDH1) and rs1 754891 3, rs1 7548907, rs2280091  (ADAM33) respectively. 
Genotyping of rs762534 (/L4), rs1 801 275, rs2074570 (/L4R), rs201 1 779, rs8056633, 
rs1 25971 88 (CDH1), rs3797054, rs1 251 5587 and rs3935792 (PCDH1) failed but could 
not be replaced by another SNP. Five SNPs were additionally excluded, three based on 
low call rates (rs2283563 (/L4R), rs7203904 (CDH1), rs528557 (ADAM33)) and two SNPs 
were not in Hardy-Weinberg Equil ibrium (HWE p-value<0.000064 (=0.05ll68); rs1 80501 2, 
rs1 8050 1 3 (/L4R)).  
Call rates for the remaining SNPs were above 95%, were in Hardy-Weinberg Equil ibrium 
(HWE) and all adolescents had less that 1 0% missing genotypes. 
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TABLE E3.1 I Area under the receiver operating characteristic curve (AUC) of models predicting 
asthma development 
Model 1 (GRS) 0.55 (0.50-0.60) 
Model 2 (In utero exposure to maternal smoking) 0.56 (0.51-0.61) 
Model 3 (Maternal asthma1 ) 0.56 (0.52-0.61) 
Model 4 (In utero exposure to maternal smoking, maternal asthma1) 0.63 (0.58-0.69) 
Model 5 (GRS, in utero exposure to maternal smoking, maternal asthma1) 0.65 (0.59-0.71) 
1 At baseline (mean age 11 yrs). GRS = genetic risk score (rs3024647 ( /L4R), rs3091307 (IL 13), 
rs12447341, rs13689, rs8061932 (CDH1) ,  rs14359, rs3822357, rs11167761, rs17097812 
(PCDH1) , rs3918396 (ADAM33)). 
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Background: The role of stress in asthma development is still unclear. We examined (1) 
whether exposure to prenatal stress, postnatal stress or stressful life events before 4 years 
is associated with asthma development up to adolescence, and (2) whether perinatal stress 
(prenatal or postnatal stress) influence the relation between stressful life events before 4 
years and asthma. 
Methods: In the population-based TRacking Adolescents' Individual Lives Survey study, 
information about exposure to prenatal stress (maternal psychological problems during 
pregnancy}, postnatal stress (maternal postnatal depression), stressful life events, and age 
of first asthma attack were retrospectively collected in 2,230 adolescents (51 % female) at 
ages 11, 14 and 16 years. Hazard ratios (HR (95% Cl)) were calculated for associations 
between stress exposures and asthma adjusted for sex and social-economic status. 
Results: Prenatal stress exposure (2.32 (1.32-4.05)) and exposure to stressful life events 
before 4 years (1.42 (1.01-1.99)) were significantly associated with asthma development; 
postnatal stress (1.70 (0.90-3.21)) approached significance. Prenatal and postnatal stress 
exposure did not significantly increase the risk of asthma associated with subsequent 
stressful life events before 4 years (HRs of the interactions 1.68 (0.38-7.35) and 2.68 (0.57-
12.48) respectively). 
Conclusion: Our study suggests that exposure to prenatal stress and stressful life events 
experienced before 4 years may increase the risk of asthma development. 
INTRODUCTION 
Asthma is a chronic inflammatory airway disease with a multifactorial etiology. A known 
risk factor for asthma exacerbations is psychosocial stress1 •2 • However, there is still debate 
whether stress also contributes to the development of asthma. Several studies suggest a 
longitudinal association between specific types of stress and asthma developmenr-1 1 • 
Studies performed in adults suggest an association between asthma development and 
family adversities experienced before the age of 183, breakup of relationships4 or stressful 
life events5• The latter study, investigating the association between 1 O stressful life events 
and asthma development, reports that especially illness of a family member, marital 
problems, divorce or separation and conflicts with a supervisor were associated with asthma 
development5• In contrast, a study performed in students aged 18-25 years did not find an 
association between stressful life events (severe disease or death of a family member and 
parental or personal conflicts) and asthma development6• 
Studies performed in children also showed an association between stress and asthma 
development7·10• These studies typically investigated asthma in children about age 7 
in relation to maternally reported early life stressors such as prenatal maternal anxiety, 
parental difficulties in the first month of life and maternal distress from birth onwards7•9• One 
study reported an association between maternal intimate partner violence during the first 3 
years of life with asthma at age 31 1 • 
None of the studies performed in children investigated the associations between exposure to 
stress and asthma development during the entire period from birth throughout adolescence, 
which is the age window at which most incident asthma cases occur. In addition, previous 
studies are mostly directed at one specific type of stress, often maternal problems occurring 
very early in life. It therefore remains unknown how stressors interact throughout the life 
course and add up to an increased risk of asthma. It is also unclear whether perinatal 
stress alters the effects of stress experienced early in life on the risk of asthma. Finally, it 
also remains unclear via which pathways stress induces asthma. The association between 
prenatal stress and asthma could for instance be explained by smoking during pregnancy or 
birth weight, given their suggested associations with both prenatal stress and with asthma 
development12-1 5• 
In a Dutch general population cohort of 2,230 adolescents, we studied the association 
between stress and asthma development. We investigated whether perinatal stress and 
exposure to stressful life events before 4 years are associated with asthma development, 
and whether this perinatal stress increases the risk of asthma associated with exposure to 
stressful life events before 4 years. Furthermore, we explored whether in utero exposure 





Study population and design 
The TRacking Adolescents' Individual Lives Survey (TRAILS) is a prospective cohort study 
among Dutch adolescents. The TRAILS sample can be regarded as representative of 
adolescents in the general population. So far, three assessment waves have been completed: 
assessment wave 1 in 2001-2002 (n=2,230, mean ± SD age 11 ± 0.6 years), assessment 
wave 2 in 2003-2004 (n=2,149, mean ± SD age 14 ± 0.5 years) and assessment wave 3 in 
2005-2007 (n=1,816, mean ± SD age 16 ± 0.7 years). Adolescents will be followed until at 
least the age of 24 years. Detailed information has been described elsewhere 16 • 
Asthma 
Data on ever having asthma, doctor diagnosis of asthma, and age of first asthma attack 
were retrospectively reported by 1,615 adolescents at mean age16 years, using the 
standardized questionnaire of the European Community Respiratory Health Survey 
(ECRHS)1 7• In adolescents who did not fill in this questionnaire (n=615), information about 
asthma was defined as parental report of asthma at the mean age 11 or 14 years18• Asthma 
development was defined as the age of first asthma attack (reported in whole years). 
Stress 
Information about exposure to prenatal stress, postnatal stress and stressful life events 
before 4 years was obtained retrospectively in a non-standardized parent interview at 
adolescent's mean age 11 years. Well-trained interviewers visited one of the parents or 
guardians (preferably the mother, 95.6%) at their homes to administer an interview covering 
a wide range of topics1 9• Prenatal exposure to stress was defined as in utero exposure to 
self-reported maternal psychological problems. Postnatal exposure to stress was defined 
as self-reported maternal postnatal depression. Exposure to stressful life events before 
4 years was defined as parental report of one or more stressful life events experienced 
by the child during the pre-school period. These stressful life events included death of a 
family member or another close person, parental divorce, and the child not living with their 
parents for at last three months. To assess the effect of exposure to stressful life events on 
asthma development, a sum score was calculated by adding up all stressful life events that 
the adolescent was exposed to. Individuals with a score of 0 were defined as not exposed, 
those with a score of � 1 were defined as exposed. 
In addition to the interview, the parent filled out self-report questionnaires, including the 
Depression Anxiety Stress Scales (DASS), a 21-item self-report questionnaire measuring 
depression, anxiety and feelings of stress in the past week. By summing scores for the 
relevant seven items, scores for depression, anxiety and stress were determined20 • 
In utero exposure to maternal smoking and birth weight 
Information about in utero exposure to maternal smoking was retrospectively reported by 
the parent at adolescent's mean age of 1 6  years using a standardized questionnaire21 • 
Information about birth weight was retrospectively assessed in the parent interview at 
adolescent's mean age of 1 1  years. It has previously been shown in this cohort that parental 
recall of birth weight and smoking during pregnancy are reliable22 • 
Social-economic status (SES) 
Social-economic status (SES) was assessed at mean age 1 1  years using 5 indicators: 
family income (low income (less than €2,500), intermediate income (€ 2,500 to € 5,500) 
and high income (greater than €5,500)), educational levels of both parents (elementary 
education, lower tracts of secondary education, higher tracts of secondary education, senior 
vocational education, and university education}, and occupational levels of both parents (low 
(elementary occupations, plant and machine operators and assemblers, craft and related 
trades workers), intermediate (skilled agricultural and fisheries workers, service workers, 
shop and market sales workers, clerks), high (technicians and associated professionals, 
professionals, legislators, senior officials, and managers)) using the International Standard 
Classification of Occupations (ISC0)23• We created a SES variable by averaging the 
indicators after standardization. The lowest 25%, intermediate 50%, and highest 25% of the 
scores were considered to represent low, intermediate and high SES, respectively24 • 
Statistical analysis 
Cox proportional hazard models were used to estimate risk of asthma development as 
a function of stress (in utero exposure to maternal psychological problems, maternal 
postnatal depression and exposure to stressful life events before 4 years) while adjusting 
for sex and SES. Because psychopathology of the informant could act as a confounder 
in the association between retrospective report of stress and asthma, Cox proportional 
hazard models estimating the effect of stress on asthma development were repeated while 
additionally adjusting for parental anxiety, depression and stress. 
To study whether perinatal stress (in utero exposure to maternal psychological problems or 
exposure to maternal postnatal depression) increases the risk of asthma associated with 
subsequent exposure to stressful life events, interactions tests were performed. If these 
interaction tests were significant, Cox proportional hazard models were used to estimate 
whether a significant effect of stressful life events before 4 years on asthma occurred, 
stratified for perinatal stress while adjusting for sex and SES. 
The third aim of our study was to explore whether prenatal risk factors for asthma (i.e. in utero 
exposure to maternal smoking or birth weight) explain the association between prenatal 
stress (in utero exposure to maternal psychological problems) and asthma development. To 
explore whether in utero exposure to maternal smoking explains the association between 
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prenatal stress and asthma development, Cox regression models were used adjusting for 
sex, SES and in utero exposure to maternal smoking. To explore whether birth weight 
explains the association between prenatal stress and asthma development, Cox regression 
models were used adjusting for sex, SES and birth weight. 
For all models, the association between stress and asthma development was studied in the 
age window after the type of stress had occurred. All reported HRs are for the presence 
versus absence of the stressor. 
Of the 224 adolescents reporting a history of asthma at the third assessment wave, age 
of first asthma attack was missing in 43. Age of first asthma attack in these adolescents 
was conservatively estimated by the age at the earliest report of asthma, which was the 
parent report at the first assessment wave (n=21) or the age at the third assessment wave 
(n=22)18• Adolescents who had not developed asthma were censored at their age at the 
third assessment wave. Adolescents who were lost to follow-up at the third assessment 
wave were censored at their age at the last assessment wave in which they participated, 
unless they had developed asthma before that age, in which case they were censored at 
the age at the earliest report of asthma, which was the parent report at the first (n=44) or 
second (n=7) assessment wave. 
The assumption of proportional hazards was assessed by inspecting log-minus-log plots 
of the survival functions. All log-minus-log plots of the investigated stressors fulfilled the 
criterion of proportionality. 
Statistical analysis were performed using SPSS Inc. Windows 18.0. P-values<0.05 (tested 
so 2-sided) were considered to be significant. 
RESULTS 
Study population 
Table 4.1 provides the summary characteristics of the study population. Of the 224 
adolescents who reported a history of asthma at the third assessment wave, 209 (93%} 
reported that a doctor had diagnosed their asthma, 10 (5%) reported that their asthma was 
not diagnosed by a doctor, and in 5 (2%) information about doctor diagnosis was missing. 
Information about age at first asthma attack was available for 181 (81 %} adolescents. 
Of the group of 2,230 adolescents, 315 (14%) were exposed to one or more stressful life 
events during the pre-school period. Of these adolescents, 300 (95%) experienced one type 
of stressful life events, 14 (4%) experienced two and 1 (1%) experienced all three types of 
stressful life events. 
TABLE 4.1 I Characteristics of the study population 
Variable Total population 
n = 2,230 
Female 
Asthma 
Birth weight (g) 




In utero exposure to maternal psychological problems 
Exposure to maternal postnatal depression 
Exposure to stressful life event before 4 years1 
Death of family member or other close person 
Parental divorce 
Child not living with their parents for at last three months 
Low social-economic status 
Intermediate social-economic status 
High social-economic status 
1 , 1 32 (51 )  
224 (1 4) 
3,390 ± 61 7 
479 (32) 





31 5 (1 4) 
1 60 (7.2) 
1 57 (7.0) 
1 4  (0.6) 
553 (25) 
1 ,084 (50) 
551 (25) 
All variables are expressed as number (percentage of non-missing values) or as mean ± SD. 1 
Death of family member or other close person, parental divorce, and the child not living with their 
parents for at last three months. 
In utero exposure to maternal psychological problems was associated with significantly 
higher exposure to maternal postnatal depression (postnatal depression present in 43 out 
of 2, 1 20 (2%) mothers without in utero exposure to maternal psychological problems versus 
7 out of 48 (1 5%) mothers with in utero exposure to maternal psychological problems (Chi­
square=32.84, p<0.001 ) ) .  Neither in utero exposure to maternal psychological problems 
nor maternal postnatal depression was significantly associated with exposure to stressful 
life events before 4 years (exposure to one of more stressful life events before 4 years in 
300 out of 2,1 23 (1 4%) adolescents without in utero exposure to psychological problems 
versus 9 out of 48 (1 9%) adolescents with in utero exposure to psychological problems 
(Chi-square=0.82, p=0.37) ; exposure to one or more stressful life events before 4 years 
in 301 out of 2, 1 23 (1 4%) adolescents without exposure to maternal postnatal depression 
versus 1 1  out of 50 (22%) adolescents with exposure to maternal postnatal depression 
(Chi-square=2.43, p=0.20)) .  
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Association between in utero exposure to maternal psychological problems and 
asthma development from birth 
In utero exposure to maternal psychological problems was positively associated with 
asthma development from birth (HR (95% Cl) 2.32 (1.32-4.05), p=0.003) (Table 4.2). 
Adjusting for parental anxiety, depression and stress did not attenuate this association (2.40 
(1.36-4.23)). Next, we explored whether prenatal factors explained the association between 
prenatal stress and asthma development from birth. We found that in utero exposure to 
maternal smoking slightly influenced the association between in utero exposure to maternal 
psychological problems and asthma development from birth (2.19 (1.11-4.29)). Birth weight 
did not attenuate the association between in utero exposure to maternal psychological 
problems and asthma development from birth (2.44 (1.39-4.27)). 
Association between exposure to maternal postnatal depression and asthma 
development from the age of 1 year 
The association between exposure to maternal postnatal depression and asthma 
development from the age of 1 year was positive, approaching significance (1.70 (0.90-
3.21 ), p=0.100) (Table 4.2). Adjusting for parental anxiety, depression and stress did not 
attenuate this association (1.74 (0.91-3.30)). 
Association between exposure to stressful life events before 4 years and asthma 
development from the age of 4 years 
Exposure to stressful life events before 4 years was positively associated with asthma 
development from the age of 4 years (1.42 (1.01-1.99), p=0.046) (Table 4.2). Adjusting for 
parental anxiety, depression and stress did not attenuate this association (1.51 (1.06-2.14)). 
Association between exposure to stressful life events before 4 years and asthma 
development from the age of 4 years in adolescents with and without exposure to 
perinatal stress (in utero exposure to maternal psychological problems or exposure 
to maternal postnatal depression) 
In utero exposure to maternal psychological problems did not significantly increase the risk 
of asthma associated with exposure to stressful life events before 4 years (HR (95% Cl) of 
the interaction between in utero exposure to maternal psychological problems and stressful 
life experienced before 4 years 1.68 (0.38-7.35)). Exposure to postnatal depression did not 
significantly increase the risk of asthma associated with exposure to stressful life events 
before 4 years (HR (95% Cl) of the interaction between exposure to postnatal depression 
and stressful life events before 4 years 2.68 (0.57-12.48)). 
TABLE 4.2 I Cox proportional hazard ratios (95% Cl) of the association between stress exposure and asthma development adjusted for sex and SES 
Type of stress Sex-adjusted HR (95% Cl) Outcome Overall Number Person-time Person-time by 
In utero exposure to maternal 2.32 (1 .32-4.05)* Asthma>0yrs psychological problems 1 
Exposure to maternal 1.70 (0.90-3.21) Asthma> 1 yrs postnatal depression 1 
Exposure to stressful life 1 .42 (1 .01 -1 .99)* Asthma>4yrs events before 4 years1 .2 














SES= social-economic status. HR= hazard ratio. Reported HR are for the presence versus absence of the stressor . All HR are adjusted for sex and SES. 
*p-value<0.05. 1 Parental interview at adolescent's mean age 11 years. 2 Death of family member or other close person, parental divorce, and the child 
not living with their parents for at last three months. 0 = Not exposed. 1 = Exposed. 
ES Stress exposure early in life is associated with asthma development 
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DISCUSSION 
We found that in utero exposure to maternal psychological problems and exposure 
to stressful l ife events before 4 years are associated with asthma development up to 
adolescence. However, we found no evidence that perinatal stress increases the risk of 
asthma associated with exposure to stressful l ife events before 4 years. We found that in 
utero exposure to maternal smoking sl ightly influenced the association between in utero 
exposure to maternal psychological problems and asthma development from birth, however, 
birth weight did not. 
The strength of this study is that it was performed in a representative sample of the general 
population, thereby increasing the probabil ity that our find ings are generalizable to the 
population at large. Moreover, we used different measures of stress exposure, including 
in utero exposure to maternal psychological problems, exposure to maternal postnatal 
depression, and exposure to stressful l ife events before 4 years. Thus, different types 
of stress, and different timings of stress were used in the analysis. Results on all stress 
measures were consistent with stress being a risk factor for asthma development, with 
particularly in utero exposure to psychological problems and exposure to stressful life 
events before 4 years being significant risk factors. 
Our results with regard to the effect of exposure to prenatal stress and stress before 4 years 
on asthma development are in line with results from other studies showing that the risk of 
asthma is higher in children of mothers with high anxiety scores during pregnancy, children 
exposed to parental difficulties in the first month of l ife, to maternal intimate partner violence 
during the first 3 years of l ife, and to continued maternal distress (depression and anxiety) 
from birth until age 77-9,1 1 • None of the aforementioned studies investigated the effect of 
exposure to stress from conception until the age of 4 years on asthma development. In 
addition, these studies are mostly directed at one specific type of stress, often maternal 
problems occurring very early in l ife .  It could be envisaged that stressors interact throughout 
one's life course and combine into an increased risk of asthma. We found nevertheless 
that exposure to prenatal stress and stressful l ife events early in life may independently 
contribute to asthma development, and that perinatal stress did not significantly increase 
the risk of asthma associated with exposure to stressful life events early in life any further. 
However, we can not fully exclude that there does not exist a cumulative effect, due to 
the relatively low numbers of asthmatics exposed to specific stressors. For instance, the 
HR (95% Cl) of exposure to stressful life events before 4 years was 8.1 5  (1 . 1 7-56.87) in 
children with prenatal stress exposure compared to 1 .39 (0.98-1 .98) in children without 
prenatal stress exposure, and these HRs (95% Cl )  were 3.33 (0.70-1 5.77) in those with 
postnatal maternal depression compared to 1 .37 (0.96- 1 .94) in those without. 
So far, it was not established if stressful life events before 4 years are associated with 
childhood development of asthma. Thus, we present new evidence that, in addition to stress 
exposure in utero, exposure to stressful life events before 4 years may increase the risk of 
asthma development from 4 years up to adolescence. 
The question arises which mechanisms may explain the associations between stress 
and asthma development. A recent study showed that prenatal maternal mood alters 
the methylation status of the human glucocorticoid receptor gene, leading to an altered 
hypothalamic-pituitary-adrenal axis (HPA axis) stress reactivity in the offspring25• Also 
cumulative chronic stress is able to alter HPA axis function26 • These findings are of interest, 
since changes in HPA axis regulation influence inflammatory processes thereby possibly 
affecting asthma development27• 
The main limitation of our study is that it was based on retrospective self-report, leading 
to potential mood and recall biases. A major influence of mood bias is unlikely, since 
adjusting for parental anxiety, depression and stress at age 11 years of the child did not 
attenuate the associations between stress and asthma development. An indication for 
recall bias with regard to stressors is that prevalences of depression during pregnancy and 
postnatal depression in our study (2% and 2%, respectively) with those in the Dutch general 
population (10% and 8%, respectively)28•29 are relatively low. Given the considerable lapse 
of time between the occurrence of the problems, it seems likely that especially severe cases 
are reported, although it could also be related to our question which only concerned the 
first month after delivery. Recall bias could also affect the report of the age at which the 
adolescent had the first asthma attack. However, validation studies of the questionnaire 
we used have shown excellent reliability over repeated assessments, while reliability was 
unaffected by either age of onset or by the difference between the age of onset and the 
age at interview3° . Retrospectively reported age of onset of asthma has been also used 
in previous studies on this topic, with much wider retrospective time intervals (asthma 
onset from age 21 onwards, age of the cohort up to 98)3. Nevertheless, although our data 
provide indications that stress and asthma development are linked, a truly prospective study 
enrolling pregnant women and following their children for symptoms of asthma would be 
optimal to address this research question. 
In summary, our study suggests that exposure to prenatal stress and stressful life events 
before 4 years are independent risk factor for asthma development. We could not find 
a cumulative effect of stress exposure on asthma development, which may be a true 
observation or the result from a still relatively small sample size of children with asthma 
development. Further prospective studies are needed to unravel the mechanisms via which 
stress leads to asthma development so that early intervention can take place to reduce the 
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ABSTRACT 
Background: We examined the association between (1) cortisol levels and asthma 
or asthma development, and (2) cortisol levels upon stress and asthma. In addition, we 
performed a post hoc meta-analysis on results from the literature. 
Methods: Cortisol, cortisol upon stress, asthma (doctor diagnosis of asthma and/or 
symptoms and/or treatment in the past 12 months) and asthma development (asthma at 
a specific survey while not having asthma at the previous survey(s)) were assessed in the 
TRAILS study (n=2,230, mean age at survey 1 11 years, survey 2 14 years and survey 3 
16 years). Logistic regression models were used to study associations between (1) cortisol 
(cortisol awakening response, area under the curve (AUC) with respect to the ground 
(AUCg) or with respect to the increase (AUCi), and evening cortisol) and asthma or asthma 
development, and (2) cortisol upon stress (AUCg or AUCi) and asthma. The meta-analysis 
included nine case-control articles on basal cortisol in asthma. 
Results: No significant association was found between (1) cortisol and asthma (age 11 
years) or asthma development (age 14 or 16 years), and (2) cortisol upon stress and 
asthma (age 16 years). The meta-analysis found lower morning and evening cortisol levels 
in asthmatics compared to non-asthmatics; however, the summary estimates were not 
significant. 
Conclusion: We found no evidence supporting a role for cortisol in asthma and asthma 
development. 
INTRODUCTION 
Asthma is a chronic inflammatory airway disorder, with many pathways involved in its 
aetiology. Psychosocial stress can trigger asthma exacerbations1 and it is suggested that 
psychosocial stress is also involved in asthma development2•6• Psychosocial stress activates 
the hypothalamic-pituitary-adrenal (HPA) axis leading to an increase in cortisol secretion 
on top of the circadian rhythm of cortisol secretion7• Cortisol influences the activity of many 
systems in the human body, including the immune system8 • Since cortisol induces a shift 
in the T-helper cell 1 (Th1 )/Th2 balance of peripheral blood mononuclear cells towards a 
predominantly Th2 response7, an alteration in HPA axis function is suggested to be one 
of the potential mechanisms via which psychosocial stress leads to asthma development. 
Several cross-sectional studies have investigated cortisol levels in asthmatics and non­
asthmatics, with d iverse results. Not only have lower9·1 1  or normal cortisol levels12-1 6 been 
reported in asthmatics compared to non-asthmatics, but also higher17• 1 8 cortisol levels have 
been reported. Since all these studies investigated different aspects of the circadian pattern 
of cortisol secretion in relation to asthma, their results are incomparable. 
Because psychosocial stress triggers asthma exacerbations\ it could be argued that 
dysfunctions of the HPA axis become more evident under stressful conditions. One 
previous study investigated both basal cortisol levels and cortisol responses to a laboratory 
stress task (Trier Social Stress Test) in asthmatics and non-asthmatics12• Although this 
study found no differences in basal cortisol levels between asthmatics and non-asthmatics, 
cortisol levels in response to a laboratory stress task were lower in asthmatics compared to 
non-asthmatics, indicating hyporesponsiveness of the HPA axis which only became evident 
under exposure to stress. Because of the small sample size of this study (asthmatics n=1 7, 
non-asthmatics n=1 8) these findings need to be repl icated in a larger sample size. 
In conclusion , results from previous cross-sectional studies have suggested that asthmatics 
have an altered HPA axis function. However, it is unclear whether this alteration in HPA 
axis function precedes the development of asthma or is the result of asthma. To our 
knowledge, no previous longitudinal study has been performed to investigate alterations in 
HPA axis function as an aetiologic mechanism contributing to the development of asthma. 
We hypothesised that (1 ) there is a cross-sectional association between low cortisol and 
asthma, (2) low cortisol levels precede the development of asthma, and (3) adolescents 
with asthma have a blunted cortisol response upon exposure to stress. 
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MATERIALS AND METHODS 
Study participants 
The Tracking Adolescents' Individual Lives Survey (TRAILS) is a prospective cohort study 
among Dutch adolescents. A detailed description of the sampling procedure and methods 
has been published previously19• Briefly, the TRAILS target sample involved 10-12-year­
olds (born between October 1, 1989 and September 30, 1990 for the first two municipalities 
or between October 1, 1990 and September 30, 1991 for the last three municipalities) living 
in five municipalities in the north of the Netherlands, including both urban and rural areas. 
A total of 135 primary schools were invited to participate, encompassing 3,483 eligible 
children. Of the 135 schools 13 refused to participate, resulting in the exclusion of 338 
children. Of the 3,145 remaining eligible children, 21 O were excluded because they were 
either unable to participate or incapable of participating due to severe mental retardation 
or due to a serious physical illness or handicap, or if no Dutch-speaking parent or parent 
surrogate was available (Turkish and Moroccan parents who were unable to speak Dutch 
were interviewed in their own language). After intensive recruitment efforts (including 
telephone calls, reminder letters and home visits), a total of 2,230 children (76.0%) were 
included in the study at baseline. So far, three assessment surveys have been completed 
(n=2,230, mean ± SD age 11 ± 0.6 years; n=2, 149, 14 ± 0.5 years; n=1,816, 16 ± 0.7 years). 
Cortisol collection at age 1 1  years 
Cortisol was assessed from saliva taken at three times during one day: shortly after waking 
up (Cort07.00); 30 minutes after waking up (Cort07.30); and at 20.00 h (Cort20.00) at age 
11 years. Saliva samples were received from 1, 768 adolescents ( details on collection and 
assays have been published previously20) .  Non-responders did not differ from responders 
92 in terms of sex; non-responders were slightly older (mean age 11.2 versus 11.1 years)20• 
Stress test and cortisol collection at age 1 6  years 
At age 16 years, 715 adolescents performed a stress test, based on (but not identical to) 
the Trier Social Stress Task21 • The stress test consisted of two parts. In the first part, the 
adolescents were instructed to prepare a 6-min speech about themselves and their lives and 
deliver this speech in front of a video camera. The speech was followed by a 3-min interlude 
in which the adolescents were not allowed to speak. In the second part, adolescents were 
asked to perform a 6-min mental arithmetic task. The adolescents were instructed to 
repeatedly subtract the number 17 from a larger sum, starting with 13,287. The mental 
arithmetic task was followed by a 3-min period of silence, after which the adolescents were 
debriefed about the experiment. Adolescents with a high risk of mental health problems 
were over-represented in this population (details in the online supplement). Cortisol was 
assessed from saliva collected prior to the stress test (Cort1 ), directly after (Cort2), and 
20 minutes (Cort3) and 40 minutes (Cort4) after the stress test (details on collection and 
assays have been published previously22} . Non-responders did not differ from responders 
in terms of sex; non-responders were slightly older (mean age 16.4 versus 16.1 year)23 • 
Asthma 
Data on asthma were collected via questionnaires at age 11 , 14 and 16 years24 • Asthma 
was defined as having a doctor diagnosis (Did a physician give your child a diagnosis of 
asthma?) (assessed at age 11 years) and/or symptoms and/or treatment for asthma in the 
past 12 months (assessed at all surveys). Asthma development was defined as having 
asthma at a specific survey, while not having asthma at all previous surveys. 
Statistical analysis 
Area under the curve with respect to the ground (AUCg) (11 years), AUCg (stress-induced), 
area under the curve with respect to the increase (AUCi) (11 years) and AUCi (stress­
induced) were calculated (formulae are in the online supplement}20•25•26• To correct for 
skewed distributions, cortisol values above or below 3 x SD of the mean were regarded 
as outliers and excluded, after which all cortisol values were transformed to z-scores to 
normalise the data in order to be able to compare results on different cortisol measures. 
Including adolescents with cortisol values below or above 3 x SD of the mean in the analysis 
did not change the results. 
Logistic regression analyses were used to study associations between basal cortisol and 
asthma at age 11 years and between basal cortisol and asthma development at age 14 and 
16 years. All analyses were adjusted for sex and quadratic effect of sampling month, since 
these are known to be associated with cortisol values20 and/or asthma24 in this cohort. 
Furthermore, logistic regression analyses were used to study associations between cortisol 
response to stress test and asthma at age 16 years, adjusted for sex and sampling weights 
to correct for the oversampling of adolescents with a high risk of mental health problems, and 
in case of AUCi (stress-induced) also for baseline cortisol level (Cort1) (online supplement) . 
All analyses were repeated adjusting for depression (affective problems scale of the Youth 
Self-Report27} , physical activity and smoking in case of basal cortisol, and additionally 
adjusting for age, body mass index (BMI) and oral contraceptive (OC) use in case of stress­
induced cortisol. A previous study in this cohort showed that age and BMI were not related 
to basal cortisoI20• 
To examine the impact of (inhaled and oral) steroid treatment on the above studied 
associations, sensitivity analyses were performed by excluding adolescents who used 
corticosteroid medication at age 1 1  years, in case of basal cortisol, or at age 1 6  years, in 
case of stress-induced cortisol. Statistical analyses were performed using SPSS Version 






Table 5.1 shows the characteristics of the study populations stratified according to asthma 
at age 11 years. 22 (1 %) Adolescents used corticosteroid-containing medication. There 
was no significant difference in age, sex and cortisol levels between adolescents with and 
without asthma at age 11 years. However, adolescents with asthma used significantly more 
corticosteroid-containing medication compared to adolescents without asthma. 
In 489 (30%) adolescents, the AUCi (11 years) was negative (cortisol levels measured at 
07.00 h were higher compared to cortisol levels measured at 07.30 h). At age 11 years, no 
significant differences were found between adolescents with a positive or a negative AUCi 
with respect to the proportion of adolescents with asthma: 34 out of 474 (7%) adolescents 
with a negative AUCi had asthma versus 73 out of 1,122 (7%) adolescents with a positive 
AUCi had asthma (Chi-squared=0.24, p=0.63). 
TABLE 5.1 I Characteristics of the study population stratified according to asthma at age 11 
years 
Age years 11.2 ± 0.6 11.1 ± 0.6 
Females 77 (50) 966 (51) 
Cort07.00 nmol/I 11.7 (0.7-100) 1 0.9 (0.9-73.3) 
Cort07.30 nmol/I 14.4 (2.0-100.0) 14.9 (0.2-131.0) 
Cort20.00 nmol/I 1.5 (0.0-8.2) 1. 7 (0.0-8.9) 
AUCg (11 years) 6.6 (1.1-13.7) 6.6 (0.5-15.5) 
AUCi (11 years) 0.8 (-3.2-4.8) 1 .0 (-5.3-7 .3) 
Corticosteroid-containing medication 1 3 (1 1 )* 9 ( 1 )  
Data are presented as number (percentage), mean ± SD or median (range). Cort07.00 = cortisol 
measured shortly after waking up. Cort07.30 = cortisol measured 30 minutes after waking up. 
Cort20.00 = cortisol measured at 20.00 h. AUCg = area under the curve with respect to the 
ground at age 11 years. AUCi = area under the curve with respect to the increase at age 11 
years. * p<0.05. 
Cross-sectional associations between cortisol levels at age 1 1  years and asthma 
Logistic regression analyses, adjusted for sex and quadratic effect of sampling month, 
showed no significant cross-sectional associations between asthma at age 11 years and 
AUCg (11 years), AUCi (11 years) or Cort20.00 h (Table 5.2). Adjusting for depression, 
physical exercise and smoking did not essentially affect the results. In addition, excluding 
adolescents using corticosteroid-containing medication did not essentially affect the results. 
TABLE 5.2 1 Estimated OR (95% Cl) of the association between basal cortisol measured at age 
11 years and asthma or asthma development adjusted for sex and quadratic effect of sampling 
month 
AUCg (11 years) 
AUCi (11 years) 
Cort20.00 nmol/L 
Asthma at age 1 1  Asthma development Asthma development 
years at age 14  years at age 1 6  years 
0.99 (0.80-1.23) 
0.91 (0.73-1.12) 







Values are shown as z-scores. AUCg = area under the curve with respect to the ground at age 
11 years. AUCi = area under the curve with respect to the increase at age 11 years. Cort20.00 = 
cortisol measured at 20.00 h.  
Longitudinal association between cortisol levels at age 1 1  years and asthma 
development at age 14 or 16 years 
Logistic regression analyses, adjusted for sex and quadratic effect of sampling month, 
showed no significant association between AUCg (11 years), AUCi (11 years) or Cort20.00, 
and asthma development at age 14 years, or age 16 years (Table 5 .2). 
Adjusting for depression, physical exercise and smoking did not essentially affect the 
results. In addition ,  excluding adolescents using corticosteroid-containing medication did 
not essentially affect the results. 
Study population stress-induced cortisol 
Table 5.3 presents the characteristics of the study population participating in the stress 
experiments, stratified according to asthma at age 16 years. 34 (5%) Adolescents used 
corticosteroid-containing medication. There was no significant difference in age, sex a nd 
cortisol levels between adolescents with and without asthma at age 16 years. Adolescents 
with asthma used significantly more corticosteroid-containing medication compared to 
adolescents without asthma. 
Cross-sectional association between cortisol levels during the stress test and asthma 
at age 16 years 
Logistic regression analysis, adjusted for sex and sampling weights to correct for the 
oversampling of adolescents with a high risk of mental health problems, showed no 
significant association between AUCg (stress-induced) and asthma at age 16 years (OR 
(95% Cl)  0.94, (0.67-1.31 )) .  Comparable results were found for the association between 
AUCi (stress-induced) and asthma at age 16 years (1.04 (0.74-1.47)) .  Adjusting for age, 
depression, physical exercise, smoking, BMI and OC use did not essentially affect the 
results. In addition ,  excluding adolescents using corticosteroid-containing medication did 
not essentially affect the results. 
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TABLE 5.3 I Characteristics of the population participating in the stress test according to asthma 
at age 16 years 
Age years 16.1 ± 0.6 16.2 ± 0.6 
Females 23 (55) 315 (51) 
Cort1 nmol/1 3.0 (0.3-10.8) 3.2 (0.0-70.1) 
Cort2 nmol/1 4.3 (0.5-9.6) 3.8 (0.0-68.0) 
Cort3 nmol/1 3.7 (1.1-11.8) 3.7 (0.0-55.5) 
Cort4 nmol/1 2.8 (0.9-16.4) 3.3 (0.0-51.5) 
AUCg (stress-induced) 226.3 (56.0-588.0) 234.0 (16.5-855.8) 
AUCi (stress-induced) 36.5 (-244.0-372.5) 16.5 (-359 .5-448.3) 
Corticosteroid-containing medication 22 (52)* 11 (2) 
Data are presented as number (percentage), mean ± SD or median (range). Cort1 = cortisol 
measured just before the stress test. Cort2 = cortisol measured direct after the stress test. Cort3 
= cortisol measured 20 min after the stress test. Cort4 = cortisol measured 40 min after the stress 
test. AUCg = area under the curve with respect to the ground (stress-induced). AUCi = area 
under the curve with respect to the increase (stress-induced). * p<0.05. 
DISCUSSION 
The present study did not show an association between basal or  stress-induced cortisol 
levels and asthma when analysing the data cross-sectionally . Furthermore, we found no 
96 association between basal cortisol levels and the development of asthma in the longitudinal 
analyses. 
This is the first study that investigated associations between basal cortisol levels and asthma 
in a large study population (n=2,230 adolescents). We found no association between basal 
cortisol measured at age 11 years and asthma at age 11 years. Previous studies have 
shown lower9-1 1 , comparable 12-1 6 and higher1 7•1 8  cortisol levels in asthmatics than non­
asthmatics. Therefore, we have performed a post hoc meta-analysis to obtain a stronger 
conclusion about the association between cortisol and asthma. To allow pooling across 
studies that used different types of H PA axis measurements, we calculated a standardised 
mean difference with 95% confidence intervals of basal cortisol levels in the morning 
and basal cortisol levels in the evening {Tables E5.1 and E5.2 in online supplement)28• 
Both morning and evening cortisol levels were lower in asthmatics than non-asthmatics; 
however, the summary estimates were not significant {Figures 5.1 and 5.2). Funnel plots 
of the morning and evening cortisol levels indicated a possible publication bias {Figures 
E5.1 and E5.2 in online supplement), suggesting unidentified unpublished articles, which 
are mostly negative or neutral articles. This potential publication bias would be compatible 
with the fact that our study, despite having the largest sample size published, failed to find 
any significant association between cortisol and asthma or asthma development. It again 
underlines the importance of publishing studies that report the absence of a significant 
association, especial ly those with large sample sizes. 
Study Name N Confidence Interval 
Fei9 36 -5.744 (-7.262, -4.227} 
Bakkeheim13 1 02 , -0.485 (-0.879, -0.091 } 
Buske-Kirschbaum 12 35 0.033 (-0.630, 0.696} 
Nomura14 74 -0.454 (-0.91 6, 0.009} 
Haen17 1 8  0.543 (-0.405, 1 .492} 
Sutherland18 31 1 .257 (0.453, 2.060} 
Griese15 28 -0.076 (-0.932, 0.779} 
Landstra10 46 -0.491 (-1 .092, 0.1 1 0} 
Kallenbach29 24 -0.090 (-0.893, 0.713} 
Overall -0,446 (-1 ,  1 1 4, 0,222} 
-7 -6 -5 -4 -3 -2 -1 0 2 
FIGURE 5.1 I Forest plot of the standardized mean differences morning cortisol levels in 
asthmatics and non-asthmatics. Test for heterogeneity Q-test Chi-square=70.04. Degrees of 
freedom=B, p<0.0001. 12 = 0.89. 
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Study Name Confidence Interval 
Fei9 -0.933 (-1 .632, -0.234) 
Bakkeheim13 , 0.000 (-0.388, 0.388) 
Hean17 0.582 (-0.369, 1 .534) 
Landstra10 :, -0.064 (-0.656, 0.529) " 
Overall ... -0. 1 36 (-0.633, 0.361 ) """ 
-1 .5 -1 .0 -0.5 0.0 0.5 1 .5 
FIGURE 5.2 I Forest plot of the standardized mean differences evening cortisol levels in 
asthmatics and non-asthmatics. Test for heterogeneity Q-test Chi-square=7.70. Degress of 
freedom=3, p=0.05. 12 = 0.61 . 
This study is the first one investigating the research question of whether alterations in HPA 
98 axis function precede asthma development. Neither asthma development at age 14 years, 
nor asthma development at age 16 years was significantly associated with basal cortisol 
levels upon awakening or evening cortisol level measured at age 11 years. Therefore, we 
did not find evidence that an alteration in HPA axis function precedes asthma development 
between ages 14 and 16 years. However, this study cannot rule out that alterations in HPA 
axis function precede adult-onset asthma. 
Contrary to a previous study that showed a blunted cortisol response to stress in 
asthmatics12, our study did not find such an association. Differences in study population 
and sample sizes could explain these inconsistent findings. The previous study included 
children (n=35, age 7-13 years), whereas our study included adolescents (n=715, age 15-
17 years). Other explanations could involve differences in the time points at which cortisol 
was measured, and differences in the way the associations between cortisol levels to a 
stress task and asthma were studied. The previous study measured cortisol 35, 25, 15 and 
1 min before, and 10, 20, 30 and 40 min after the stress test and compared individual time 
points between asthmatic and healthy children. Our study measured cortisol at the start, 
directly after, and 20 and 40 min after the end of the stress test and investigated whether 
AUC was associated with asthma. When investigating individual cortisol levels measured 
at 20 and 40 min after the stress test in our study, we found no differences in cortisol levels 
between asthmatics and non-asthmatics (l.1=12,731.0, p=0.98 and l.1=11,453.0, p=0.39, 
respectively). Therefore, our data suggest that cortisol responses upon exposure to stress 
are not associated with asthma. 
The strength of this study is its longitudinal design, allowing us to study the effect of cortisol 
prior to the onset of asthma. In addition, our study was performed in a large sample of 
the general population, thereby increasing the probability that our findings with respect to 
basal cortisol levels are generalisable to the population at large. However, this advantage 
of the large sample size comes with some associated disadvantages, especially the level 
of detail that was reached in the phenotyping of asthma and in the characterisation of 
HPA axis activity in our study. The asthma population in our study is heterogeneous in 
terms of phenotype, severity and management. Therefore, we may have missed potential 
associations with cortisol in specific subgroups such as those with nocturnal asthma or 
allergic asthma. We do not have information about whether adolescents with asthma have 
allergic or non-allergic asthma. However, we do have information about the presence of 
allergy, hay fever and eczema, which made it possible to give some indication whether 
asthmatic adolescents in our study have allergic (asthma with allergy, hay fever or eczema) 
or non-allergic asthma (asthma without allergy, hay fever and eczema). Sensitivity analysis 
revealed comparable associations with cortisol for allergic and non-allergic asthma (data 
not shown). 
With respect to the characterisation of the HPA axis activity, cortisol was assessed at 1 
day in our study. Previous studies showed that cortisol levels have notable intra-individual 
variability12•1 6, which is reduced when sampling on a workday, as a result of the usually strict 
schemes30• In our study, cortisol was mostly assessed on school days, which are highly 
scheduled as well, so we expect that the same reduction in intra-individual variability applies 
to our adolescents. In addition, we expect that the large sample size will compensate for 
the possible reduction in reliability as a result of one day cortisol assessment, so random 
fluctuations in individual values will be set off. 
In our study, cortisol was assessed at three time points, namely shortly after waking up (still 
lying in bed), 30 min after waking up and at 20.00 h. As a consequence only the cortisol 
awakening response and cortisol levels at 20.00 h could be studied in relation to asthma 
and asthma development, and not the circadian rhythm of the cortisol secretion. Therefore, 
we cannot rule out that there is an association between specific elements of this circadian 
rhythm of cortisol secretion and asthma presence or development. 
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We were unable to find evidence suggesting a role for cortisol in asthma, despite its well­
established anti-inflammatory properties and therapeutic effects when given as inhaled 
or oral corticosteroids. The question arises whether our study indicates a real lack of 
association, or whether it merely reflects the problems associated with large cohort studies. 
Further prospective studies are needed to unravel the role of cortisol in asthma or asthma 
development. It is pivotal for such studies that both cortisol and asthma are measured in 
detail. For cortisol, this implies measuring multiple time points and multiple days, in order to 
obtain a reliable and robust estimate of HPA axis activity. For asthma, detailed phenotyping 
would enable the study of differences in the association with cortisol in relation to asthma 
severity and medication use, and also in relation to subtypes, including glucocorticoid 
resistant asthma or non-allergic asthma. Complaints of nocturnal worsening are especially 
interesting because of the circadian rhythm of cortisol secretion and the anti-inflammatory 
effect of cortisol. 
In summary, our study did not find evidence supporting a role for cortisol in asthma and 
asthma development. In addition, our study found no association between stress-induced 
cortisol levels and asthma. Further longitudinal studies from birth onward have to assess 
whether there exists a window of time in which alterations in HPA axis function may 
contribute to asthma development. However, in adolescence, it seems unlikely that this 
plays a dominant role. 
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ONLINE SUPPLEMENT 
Selection of adolescents performing a stress test 
The laboratory tasks started between 08.00 h and 09.30 h (morning sessions, 49%) and 
13.00 h and 14.30 h (afternoon sessions, 51%). The costly and labor-intensive nature of 
the experimental session precluded assessing the whole sample. To increase the power 
to detect mental health-related differences in the stress response, adolescents with a high 
risk of mental health problems ha d a greater chance of being selected for the laboratory 
tasks session compared to healthy adolescents. High risk was defined based on three 
criteria: (1) temperament assessed by the revised parental version of the Early Adolescent 
Temperament Questionnaire, (EATQ; i.e. , high scores on frustration ( �  90th percentile of 
EATQ) , and fearfulness ( � 90th percentile of EATQ), low scores on effortful control ( � 
10th percentile of EATQ)), (2) lifetime parental psychopathology (at least one parent with 
depression, anxiety, addiction , psychosis, or antisocial behavior), and (3) environmental 
risk (at least one of the biological parents was raised in a single-parent family), all assessed 
at age 11 years. In total, 66% had at least one of the above-described risk factors. The 
remaining 34% were randomly selected from the total TRAILS cohort. Please note that the 
focus sample still represented the whole range of problems seen in a normal population 
of adolescents, which made it possible to reproduce the distribution in the total TRAILS 
sample by means of sampling weights. 
The study protocol was approved by the Central Committee on Research Involving Human 
Participants (CCMO). 
Participants provided written informed consent. Forty-two (6%) adolescents had asthma, 
and 34 (5%) adolescents used corticosteroid-containing medication. 
Stress task 
The stress test consisted of two parts. In the first part, the adolescents were instructed to 
prepare a 6-minute speech about themselves and their lives and deliver this speech in 
front of a video camera. They were told that their videotaped performance would be judged 
by a panel of peers after the experiment. The adolescents had to speak continuously for 
the whole period of 6 minutes. The test assistant watched the performance critically, and 
showed no empathy or encouragement. The speech was followed by a 3-minute interlude in 
which the adolescents were not allowed to speak. During this interval, the adolescents were 
told that they had to wait for a moment because of computer problems, but that the task 
would continue as soon as the problems were solved. In the second part, adolescents were 
asked to perform a mental arithmic task. The adolescents were instructed to repeatedly 
subtract the number 17 from a larger sum, starting with 13,287. This difficult task was meant 
to induce a sense of uncontrollability. Uncontrollability was further provoked by negative 
feedback by the test assistant, including remarks such as, "No, wrong again, begin at 
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1 3,278", "Stop wiggling your hands" or "You are too slow, be as quick as you can, we 
are running out of schedule". The mental arithmetic challenge lasted for 6 minutes, again 
followed by a 3-minute period of silence, after which the adolescents were debriefed about 
the experiment. 
Statistical analysis 
With respect to cortisol measured upon awakening at age 1 1  years, the AUCg (1 1 years) 
was calculated using the formula (Cort07.30 - Cort07.00)* 0.5 / 2 + 0.5 * Cort07.00. The 
AUCi (1 1 years) was calculated using the formula (Cort07.30 - Cort07.00) * 0.5 / 2. 
With respect to cortisol measured during the stress test, the AUCg (stress-induced) was 
calculated using the formula: (Cort1 + Cort2)* 25/2 + (Cort2 + Cort3)* 20/2 + (Cort3 + 
Cort4)*20/2. The AUCi (stress-induced) was calculated using the formula (Cort1 + Cort2)* 
25/2 + (Cort2 + Cort3)* 20/2 + (Cort3 + Cort4)*20/2 - Cort1 *65. 
Search strategy for the meta-analysis 
Relevant articles were identified by searching the database of Medline. The following search 
string was used to identify articles: the first component consisted of asthma; the second 
component consisted of the terms hypothalamic-pituitary-adrenal axis, pituitary-adrenal 
and cortisol; the third component consisted of the terms human, children, adolescents, 
childhood, adulthood, adult, adults. 
Extraction of cortisol data 
Morning and evening mean cortisol levels and standard deviations from asthmatics and non­
asthmatics were extracted from the case-control studies or in case of missing information 
where calculated for each study. When cortisol levels were divided in nocturnal and non­
nocturnal asthma or in mild and moderate-to-severe asthma, a pooled mean cortisol level 
and a pooled standard deviation was calculated. One study was excluded from the meta­
analysis because calculation of mean cortisol levels and standard deviation in asthmatics 
and non-asthmatics was not possible. Relevant articles were identified by searching the 
database of Medline (published between 201 2  and 1 985). The fol lowing search string was 
used to identify articles: the first component consisted of asthma; the second component 
consisted of the terms hypothalamic-pituitary-adrenal axis, pituitary-adrenal and cortisol; the 
third component consisted of the terms human, children, adolescents, childhood, adulthood, 
adult, adults. This resulted in 601 articles. Title and abstract of relevant articles were 
screened based on: ( 1 ) case-control studies; (2) measurement of asthma; (3) measurement 
of HPA axis. Articles written in another language than English, articles studying the effect 
of treatment on HPA axis function, articles studying HPA axis under provocation tests or 
stress (test), and clinical trials were excluded. Full text of 1 1  articles was acquired. In case 
of suspected duplicate reports of the same subjects the original authors were contacted to 
detect overlap of individuals. This resulted in the exclusion of 1 article. In addition, 1 article 
was excluded because no basal cortisol levels could be calculated from the information 
provided in the study. 
Statistical software used for pooling the data 
Meta-analyst (http://www.medepi .net/meta/MetaAnalyst.html) was used for pooling of 
the data. The present of heterogeneity was calculated by the Q statistic (Chi-square test 
calculating whether variation in study results is due to chance variation or whether variation 
is due to systematic underlying differences and the null hypothesis should be rejected) and 
the 12 statistic (the percentage of variability in the results that is caused by heterogeneity 
rather than coincidence). 
Allergic and non-allergic asthma 
Parentally reported information about allergy, hay fever and eczema was assessed at age 
1 1 ,  1 4  and 1 6  years. Allergic asthma was defined as having asthma at a specific survey 
with allergy, hay fever or eczema at that survey. Non-al lergic asthma was defined as having 
asthma at a specific survey without allergy, hay fever or eczema at that survey. 
Logistic regression models were used to study the association of basal cortisol with allergic 
and non-allergic asthma, adjusted for sex and quadratic effect of sampling month. Logistic 
regression models were used to study the association of stress-induced cortisol with 
allergic and non-allergic asthma, adjusted for sex and sampling weights to correct for the 
oversampling on high risk of mental health problems in case of AUCg (stress test) and 
additionally for baseline cortisol level (Cort1 ) in case of AUCi (stress test) . 
TABLE E5.1 I Overview of studies included in the meta-analysis comparing standardized mean 
differences of morning cortisol levels 
Study Saliva/ Cases Controls 
Serum 
Fei9 

















n = number. SD = standard deviation. 
n Mean SD n Mean SD 
(ng/ml) (ng/ml) (ng/ml) (ng/ml) 
21 4.0 0 .8 15 9.1 1.0 
50 3.1 1.7 52 3.9 1.6 
17 7.8 3.0 18 7.7 3.1 
35 46.2 19.3 39 56.4 25.0 
10 250.1 103.3 8 206.6 30.8 
20 155.3 37.7 11 107.0 39.8 
21 126.9 77.7 7 132.5 55.8 
28 116.0 86.3 18 159.5 92.3 




TABLE ES.2 I Overview of studies included in the meta-analysis comparing standardized mean 
differences of evening cortisol levels 
Fei9 Saliva 21 2 .9 0.6 1 5  3.5 0.7 
Bakkeheim13 Saliva 50 0.3 0.1 52 0.3 0.2 
Hean11 Serum 1 0  54.4 34.4 8 32.6 41 .0 
Landstra10 Serum 28 32.6 95.9 1 8  38. 1 69.2 
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TO THE EDITORS: 
Asthma is  a multifactorial disease. Although a number of host and environmental risk 
factors have been identified in the past decades, these cannot fully explain the prevalence 
of asthma. Previous studies have shown that psychosocial stress confers a risk for the 
development of asthma 1 • 
Stress activates the hypothalamus-pituitary-adrenal (HPA) axis, w hich leads to secretion 
of cortisol. Cortisol in turn influences the activity of many systems in the human body 
and shifts, among others, the T-helper type (Th1/fh2) balance of the peripheral blood 
mononuclear cells towards a predominantly type 2 response. Cortisol binds to the high 
affinity mineralocorticoid receptor (NR3C2) and the low affinity glucocorticoid receptor 
(NR3C1) . Single nucleotide polymorphisms (SNPs) in these receptors have been associated 
with basal cortisol and cortisol responses to stress2 • So far, two studies have found an 
association between SNPs in NR3C1 (i.e. rs61 95, rs41 423247) and asthma development3.4. 
However, these results have not been replicated in other populations so far. Additionally, 
it is unknown whether other functional or tagging SNPs in the NR3C1 are associated with 
asthma development. In addition,  SNPs in the NR3C2 have not been studied before in 
relation to asthma development. Also it is yet unclear whether exposure to psychosocial 
stress modifies the effect of SNPs in NR3C2 or NR3C1 on asthma. 
We investigated the associations of SNPs in NR3C2 or NR3C1 with asthma in adolescents 
from the general population and attempted to replicate our findings in an asthma case­
control study. 
In adolescents from the general population, we have previously shown that exposure to 
perinatal stress more than doubles the risk of asthma development5• Therefore, we tested 
additionally whether exposure to perinatal stress modifies the effect of SNPs in NR3C2 or 
NR3C1 on asthma in adolescents. 
We genotyped two functional SNPs in NR3C2 (rs5522, rs2070951 ) and 1 2  functional or 
tagging SNPs in NR3C1 (rs491 2903, rs61 98, rs61 96, rs25881 3,  rs33388, rs1 71 00236, 
rs1 0482642, rs29631 55, rs41 423247, rs9324924, rs4244032, rs4607376) in 1 ,454 
adolescents of the prospective TRacking Adolescents' Individual Lives Survey (TRAILS) 
cohort (48% males; mean ± SD age at survey 1 ,  1 1  ± 0.6 yrs; survey 2, 14 ± 0.5 yrs; survey 
3, 1 6  ± 0.7 yrs)6 and in 998 individuals from the Dutch Asthma GWAS study (44% males; 
mean ± SD age 42 ± 1 2.2 yrs)7, that acted as replication study. In  TRAILS, data on parental ly 
reported asthma was collected at age 1 1 ,  1 4  and 1 6  yrs via self-reported questionnaires8• 
Asthma was defined as a doctor diagnosis of asthma, and/or symptoms of asthma and/or 
asthma treatment prescribed by a physician in the past 12 months, before or at the age of 
16 years (n=141 (10%)). Adolescents not meeting these criteria were defined as not having 
asthma (n=1,293 (89%)). Information about asthma was missing in 20 adolescents (1 %). 
The replication study consisted of 529 asthmatics and 469 non-asthmatics; asthma was 
defined as a doctor's diagnosis of asthma, the presence of asthma symptoms and bronchial 
hyperresponsiveness7 • In TRAILS, perinatal stress was defined as in utero exposure to 
the mother's self-reported maternal psychological problems and/or self-reported maternal 
postnatal depression (n=67 adolescents (5%))9. 
SNPs were analysed in an additive genetic model for the effect on asthma using logistic 
regression models. Interactions between genotype and perinatal stress were tested in 
TRAILS by introduction of perinatal stress and the interaction term of genotype times 
perinatal stress into the model. 
None of the SNPs in NR3C2 or NR3C1 were significantly associated with asthma in 
adolescents. We also found no association between these SNPs in NR3C2 or NR3C1 and 
asthma in the replication study (Table 6.1 ) .  
We observed no effect of perinatal stress on the association between SNPs in NR3C2 or 
NR3C1 and asthma in adolescents (i.e. no interaction between perinatal stress and SNPs) .  
Previous studies have shown that SNPs in NR3C1 (i.e. rs6195, rs41423247) were 
associated with asthma3•4• Our results do not support the findings of these previous studies, 
specifically not those suggesting that a mutation (G/C) within rs41423247 in NR3C1 would 
have a protective effect on asthma development4. However, this association was shown 
in merely one study including only 59 adults with asthma and 70 healthy adults. Since we 
found neither an association between rs4142324 7 and asthma in 1,434 adolescents (OR 
(95% Cl) 0.99 (0.76-1.28)) nor in 998 adult individuals (0.96 (0.80- 1.15)), we feel that the 
findings from the study of PIETRAS et a/.4 may be due to chance. 
Although we found no association between SNPs in the glucocorticoid or mineralocorticoid 
receptor and asthma, this does not exclude a role of glucocorticoid or mineralocorticoid 
receptor activity in asthma development, since this activity is influenced by multiple other 
mechanisms, such as chaperone proteins that modulate the translocation of these receptors 
and post-translation changes that modify the conformation of these receptors. In addition, 
methylation of both receptors can also influence whether cortisol levels are associated with 





TABLE 6.1 I Estimated associations between single nucleotide polymorphisms in NR3C2 or 
NR3C1 and asthma in the TRacking Adolescents' Individual Lives Survey (TRAILS) cohort study# 
and the Dutch Asthma GWAS (DAG) study 
NR3C2 (chromosome 4) 
rs5522 G (13) 0.88 (0.60-1.29) C (14) 1.24 (0.96-1.60) 
rs2070951 G (49) 1.27 (0.98-1.63) G (53) 0.93 (0.78-1.10) 
NR3C1 (chromosome 5) 
rs4912903 A (40) 0.92 (0.71-1.18) T (43) 0.96 (0.81-1.14) 
rs6198§ G (16) 0.87 (0.62-1.22) G (18) 0.84 (0.67-1.06) 
rs6196 r G (15) 1.12 (0.80-1.56) C (16) 0.90 (0.70-1.15) 
rs258813 A (31) 0.99 (0.76-1.29) A (33) 0.86 (0.72-1.04) 
rs33388 T (47) 1.11 (0.86-1 .42) T (45) 1.15 (0.96 (1.36) 
rs17100236 G (13) 1.14 (0.81-1.62) C (11) 1.21 (0.91-1.60) 
rs10482642 G (16) 0.87 (0.62-1.22) C (18) 0.85 (0.68-1.07) 
rs2963155 G (23) 1.21 (0.91-1.61) G (22) 1.10 (0.88-1.37) 
rs4142324 7## C (37) 0.99 (0.76-1.28) G (37) 0.96 (0.80-1.15) 
rs9324924 A (33) 1.03 (0.80-1.33) T (29) 0.97 (0.77-1.22) 
rs4244032 G (20) 1.00 (0.73-1.37) G (20) 0.87 (0.62-1.23) 
rs4607376 G (50) 0.98 (0.77-1.26) G (50) 0.98 (0.82-1.17) 
# Information about asthma missing in 20 adolescents. 11 n=1,434, 141 cases and 1,293 controls. 
+ n=998, 529 cases and 469 controls. MAF = minor allele frequency. NR3C2 = mineralocorticoid 
receptor gene. NR3C1 = glucocorticoid receptor gene. § In DAG study genotyped with rs11740792 
(r2=1 ). r In DAG study genotyped with rs9324918 (r2=1 ). ## In DAG study genotyped with rs853180 
(r2=0.965). 
In conclusion, we show suggestive evidence that SNPs in NR3C2 or NR3C1 are not 
associated with asthma development. We also find no indications that perinatal stress 
would affect the role of these genes on asthma development. These results indicate that, 
while these genes are biologically plausible candidate genes for asthma development in 
relation to perinatal stress, they cannot be linked to the disease. 
We are grateful to all adolescents, their parents and teachers who participated in this 
research and to everyone who worked on this project and made it possible. 
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The aims of this thesis were to unravel the paths from early life stress to the development 
of asthma up to adolescence, and to quantify the relative contribution of the mediating 
mechanisms via which stress leads to asthma development. We first focused on the role 
of pubertal development, and on the gender-related switch in asthma prevalence and the 
genetic pathways involved in asthma development. In the current chapter, all findings will be 
integrated and discussed, resulting in a new perspective on the role of psychosocial stress 
in asthma development. 
MAIN FINDINGS OF THIS THESIS 
In the TRAILS study, asthma prevalence at age 11 years was 8% for boys and 7% for girls. 
However, a gender switch occurred in asthma prevalence after age 11, resulting in a higher 
asthma prevalence in females (6%) than males (4%) at age 16 years. This gender switch in 
asthma prevalence could not be explained by pubertal stages. 
Multiple genes (such as genes involved in allergy (/L4, IL4R and IL 13), epithelial integrity 
(CDH1 and PCDH1) or airway remodeling (ADAM33)) are known to be associated with 
asthma or asthma-related phenotypes. The effects of SNPs in these genes on asthma 
risk are mostly modest. Therefore, we assessed whether combining the effects of SNPs in 
these genes into a genetic risk score (GRS) might result in a better prediction of asthma 
development. Results from this thesis show that the GRS is a highly significant independent 
predictor of asthma, even when other risk factors for asthma development, such as in utero 
exposure to maternal smoking and maternal asthma, are taken into account. Moreover, 
the effect of the GRS on asthma development is not dependent on in utero exposure to 
maternal smoking or maternal asthma. 
Next to genetic and environmental factors, also exposure to psychosocial stress is 
suggested to be associated with asthma development. Results from this thesis suggest that 
exposure to prenatal stress and stressful life events experienced before 4 years increases 
the risk to develop asthma. However, the mechanisms underlying this association are 
yet unclear. Exposure to psychosocial stress leads to an increase in cortisol secretion. 
Cortisol influences many systems in the human body, among others the immune system 
where it induces a shift in the Th1/fh2 balance towards a Th2 inflammatory response. 
Therefore, we hypothesized that changes in cortisol levels would be associated with asthma 
or asthma development. Results from this thesis show that there is no association between 
basal or stress-induced cortisol and asthma, indicating that the HPA axis functioning in 
asthmatic adolescents is not different from that in non-asthmatic adolescents in our 
cohort. Moreover, we found no significant association between basal cortisol and asthma 
development, indicating that cortisol changes do not precede the development of asthma 
during this age span. Next, we also studied whether SNPs in genes associated with HPA 
axis functioning, i .e. NR3C1 and NR3C2, are associated with asthma. In addition, we tested 
whether the association between SNPs in these genes and asthma were dependent on 
exposure to perinatal stress. We found no effect of SNPs in NR3C1 or NR3C2 on asthma. 
Moreover, exposure to perinatal stress did not influence these associations. Other plausible 
mechanisms that can underlie the stress-asthma association are health-risk behaviors, 
such as in utero exposure to maternal smoking and overweight. Results from this thesis 
suggest that in utero exposure to maternal smoking explains a small part of the association 
between exposure to psychosocial stress and asthma development, however, birth weight 
does not. 
In the first section of the discussion, these main findings are interpreted and discussed 
while considering the possible methodological strengths and limitations of our studies. In 
the second part of the discussion, the clinical relevance of the thesis findings is discussed. 
The thesis will end with suggestions for further research to unravel the paths from early 
life stress to the development of asthma up to adolescence, and to quantify the relative 
contribution of the mediating mechanisms via which stress leads to asthma development. 
PSYCHOSOCIAL STRESS AS RISK FACTOR FOR 
ASTHMA DEVELOPMENT 
Evidence from both cross-sectional and longitudinal studies performed in children, 
adolescents and adults suggests that psychosocial stress is involved in the etiology of 
asthma1 •22 (Tables 1 .1 and 1 .2). However, there are still a number of important questions 
that remain to be clarified regarding the role of subjective experience of a stressor, the timing 
of the exposure to the stressor, modification of the effect of stress on asthma development 
by genetic susceptibility, and the mechanisms via which stress can lead to asthma 
development. In the following part of the discussion, these questions will be approached. 
THE ROLE OF THE OBJECTIVE EXPOSURE TO A 
STRESSOR VERSUS THE SUBJECTIVE EXPERIENCE OF 
A STRESSOR ON ASTHMA DEVELOPMENT 
For the effect of stress on human health, it is known that both the presence of a stressor 
(objective stress exposure) and the subjective experience of a stressor are important. Most 
previous studies investigated the role of objective stressors on asthma development1 •2 •5•22• 
These studies investigated a broad variety of stressors, ranging from exposure to a stressor 
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experienced by the subjects themselves (i.e. stressful life events, physical/sexual abuse 
or job stress) to exposure to a stressor experienced by others such as the parents (i.e. 
maternal anxiety or death of a child or spouse). Results from these studies mostly showed 
that exposure to an objective stressor is associated with an increased risk to develop 
asthma (Tables 1 .1 and 1 .2). Only two previous studies have investigated the role of the 
subjective experience of a stressor on asthma development, namely parental difficulties 
measured at the age of 3 weeks3•4• These studies found that the subjective experience of 
a stressor is associated with asthma development as well (Table 1 .1 ). As far as we know, 
no previous study has investigated both the effect of objective exposure to stress and the 
effect of the subjective experience of stress on asthma development. Therefore, it was 
unknown whether the effect of stress on asthma development applies to both the objective 
stress exposure as well as the subjective experience of stress exposure. In chapter 4, we 
investigated whether objective exposure to stress, namely in utero exposure to maternal 
psychological problems, postnatal depression and stressful life events before 4 years, is 
associated with the development of asthma up to adolescence. Moreover, we also explored 
whether the subjective experience of stress ("How many unpleasant events did you 
experience between the age of O and 5 ( or 6 and 1 1 ) years", ranging form O ("no unpleasant 
events experienced") to 1 0  ("very many unpleasant events experienced") is associated 
with asthma development. We found that in utero exposure to maternal psychological 
problems and exposure to stressful life events before 4 years are significantly associated 
with asthma development up to adolescence. In addition, we found a positive association 
between exposure to postnatal depression and asthma development up to adolescence, 
although this effect was of borderline significance (Table 4.2). These results indicate that 
psychosocial stress exposure early in life is associated with asthma development. Next, 
we explored the effect of the subjective experience of stress on asthma development. We 
found that the experience of unpleasant events between the ages 0-5 years is associated 
with asthma development from the age of 6 years (HR (95% Cl) 1 .28 (0.94-1 .75)), although 
this association is borderline significant (p=0.1 2). No association was found between the 
experience of unpleasant events between the ages 6-1 1 years and asthma development 
from the age of 1 2  years (1 .27 (0.66-2.46)) {data not shown). These results suggest that 
there might be an effect of the subjective experience of stress, at least at young ages, 
on asthma development. Although both the objective and the subjective stress measures 
showed an effect of stress on asthma development, the effect on asthma development was 
stronger for the objective stress measure than for the subjective stress measures. This might 
be due to the fact that the time window in which the stress measures were assessed differed 
between the objective stress measure (0-3 years) and the subjective stress measures 
(0-5 and 6-1 1  years). However, the most plausible explanation for the fact that the effect 
on asthma development differed between the objective and subjective measures is that 
they assess different types of stress exposure. The objective stress measure assessed 
exposure to stressful life events such as death of a family member, death of another close 
person, parental divorce and the child not living with their parents for at last three months. 
A sum score was calculated by adding up all stressful life events that the adolescent was 
exposed to in the first 4 years of life, and adolescents with a sum score of O were defined 
as not exposed, whereas those with a sum score of � 1 were defined as exposed. The 
subjective stress measure assessed exposure to unpleasant events (between 0-5 and 6-11 
years). Adolescents filled in a Likert linear analog scale ranging from O ("no unpleasant 
events experienced") to 10 (''very many unpleasant events experienced"). In this measure, 
adolescents with a score of O were defined as not exposed, whereas those with a score 
of � 1 were defined as exposed. In the latter measure, no information was available about 
the exact nature of the unpleasant events the adolescents were exposed to. Thus, not only 
severe life events but also less severe life events or daily problems could be incorporated 
in this measure. In addition, the personality of the adolescent will have played an important 
role in perceiving how unpleasant an event was. 
Results from previous studies support our hypothesis that the risk to develop asthma 
is increased with exposure to life events that are of more severe nature. These studies 
found that especially physical or sexual abuse7•16•18, violence8•10-13,1a,1 9, illness or death of a 
family member14•18, divorce/breaking off a life partnership14•21 , and war-related stress1 7  were 
associated with an increased risk to develop asthma. 
CRITICAL PERIOD MODEL VERSUS THE 
ACCUMULATION OF RISK MODEL 
Two main pathways have been identified via which early life experiences can affect health 
later in life, namely the critical period model and the accumulation of risk model. The critical 
period model underlies the fetal origins of the adult disease hypothesis, whereas the 
accumulation of risk model assumes that the effects of stress accumulate gradually over 
time. In chapter 4, we investigated which of the above mentioned models can be applied to 
the stress-asthma association. We found that in utero exposure to maternal psychological 
problems and exposure to stressful life events before 4 years are significantly associated 
with asthma development up to adolescence. In addition, we found a positive association 
between exposure to postnatal depression and asthma development up to adolescence 
(borderline significance; p=0.10). When investigating the effect of stress exposure during 
these specific time points on asthma development, we found that exposure to stress during 
the prenatal period is associated with the highest risk to develop asthma. Moreover, we 
found that the risk to develop asthma as a result of exposure to stress decreases with the 
passage of time. This could indicate that indeed the critical period model fits the stress­
asthma association; however, it could also be the result of the fact that different stress 
measures were used during different time periods, namely in utero exposure to maternal 
psychological problems (prenatal period), postnatal depression (postnatal period) and 
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stressful life events (early childhood). Previous studies have also investigated stress 
exposure during the perinatal period. Results from these studies are in line with our 
observations, namely that exposure to stress during the perinatal period is associated with 
asthma development. These studies typically investigated asthma development in relation 
to maternal anxiety during pregnancy1 , death of a child or a spouse during pregnancy2 , 
parental difficulties in the first month of life3•4 and stressful life events during their first year of 
life6 {Table 1.1 ). Therefore it seems plausible that the critical period model is the model that 
best fits the observed stress-asthma association. 
Does the former summary imply that the accumulation of risk model does not fit to the 
stress-asthma association? This model assumes that the risk of asthma accumulates 
with stress exposure over time independent of the timing of the exposure. We tried to 
investigate whether this accumulation of risk model fitted to the stress-asthma association 
by investigating whether the effect of stress exposure during early life (i.e. stressful life 
events before age 4 years) on asthma development was increased in those adolescents 
that were exposed to perinatal stress (i.e. in utero exposure to maternal psychological 
problems or postnatal depression). We did not find an effect of exposure to perinatal stress 
on the association between stress exposure during early life and asthma development in 
our study (chapter 4) . This indicates that the accumulation of risk model does not fit the 
observed stress-asthma association. However, it is known that not only the objective stress 
exposure, but also the subjective stress exposure is important for asthma development. 
Therefore we also explored whether the effect of the subjective experiencing of stress from 
birth onwards on asthma development was increased in adolescents that were exposed to 
stress during the perinatal period. We found that within adolescents exposed to prenatal 
stress, the risk to develop asthma as a result of exposure to unpleasant events experienced 
between ages 0-5 years is higher (OR (95% Cl) = 2.44 {0.28-21 .45)) than in adolescents 
not exposed to prenatal stress (1.23 (0.90-1.69)), although the HRs are not significantly 
different between both groups. However, this accumulative effect of stress exposure 
does not apply to exposure to postnatal stress (1.39 (0.27-7.19) versus 1.26 (0.92-1.73) 
respectively for adolescents exposed to postnatal depression and those not exposed) ( data 
not shown). Moreover, we were not able to perform comparable analysis for unpleasant 
events experienced between ages 6-11 years, since all but one adolescent with perinatal 
stress who developed asthma did this before the age of 12 years. Overall, results from 
our study do not confirm the accumulation of risk model in the stress-asthma association. 
However, our data regarding the effect of subjective stress exposure between ages 6-11 
years could also not fully exclude that there is no effect of accumulative stress exposure 
on asthma development since practically all adolescent with perinatal stress developed 
asthma at an early age. Further studies in larger groups are needed to investigate whether 
there is indeed an accumulative effect of stress on asthma development. 
MODIFICATION OF THE EFFECT OF STRESS ON ASTHMA 
DEVELOPMENT BY GENETIC SUSCEPTIBILITY 
A well-known model in psychiatry is the stress-vulnerability model, which basically states 
that stress may lead to psychiatric problems if an underlying vulnerability is present. 
Previous studies investigating children with a familial predisposition for asthma found that 
exposure to stress increases the risk to develop asthma3•4•6• However, it is not clear whether 
this effect of stress on asthma development was dependent on the genetic vulnerability to 
develop asthma, since these studies did not include children without a familial predisposition 
for asthma. In addition, if the effect of stress exposure on asthma development would be 
dependent on an underlying genetic predisposition, the genes underlying this effect are yet 
unknown. 
We applied the stress-vulnerability model to stress-asthma association. In chapter 4 we 
investigated the effect of stress exposure during the prenatal period (i.e. in utero exposure 
to maternal psychological problems), the postnatal period (i.e. postnatal depression) and 
early childhood (i.e. stressful life events before age 4 years) on asthma development. In 
addition, we explored whether the effect of prenatal and postnatal stress exposure on asthma 
development was modified by parental asthma. We showed that stress exposure during 
the perinatal period and early childhood increased the risk to develop asthma. However, 
our results did not support the hypothesis that the effect of stress on asthma development 
is dependent on parental asthma. Neither the interaction term between prenatal stress 
exposure and parental asthma nor that of postnatal stress exposure and parental asthma 
are significant (data not shown). 
Next, we explored whether the genetic background of an adolescent modifies the effect of 
perinatal stress exposure (i.e. in utero exposure to maternal psychological problems and/or 
postnatal depression) on asthma development. Plausible genes that can modify the effect 
of stress on asthma development are genes known to be associated with asthma (such 
as IL4, IL4R, IL 13, CDH1, PCDH1 or ADAM33). Since the effect of a single SNP in these 
genes on asthma development are mostly modest, we investigated whether a genetic risk 
score (GRS), that combines the effects of these individual SNPs, is associated with asthma 
development to get a better prediction of the genetic contribution to asthma development 
(chapter 3). We found that a GRS is a strong predictor for asthma, even after correcting for 
other risk factors known to be associated with asthma development, being in utero exposure 
to maternal smoking and maternal asthma. Due to low numbers of adolescents exposed to 
perinatal stress, the modifying effect of perinatal stress (i.e. in utero exposure to maternal 
psychological problems and/or postnatal depression) on the association between GRS and 
asthma could not be studied. 
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Next to the genes mentioned above, there are other plausible genes that can modify 
the effect of stress on asthma development. Exposure to stress leads to an increase 
in cortisol secretion. Cortisol exerts his effects via binding to the glucocorticoid and the 
mineralocorticoid receptor. It is known that deficits in the activity of these receptors modify 
the effect of cortisol on end organs, e.g. the immunosuppressive effect in the lungs23• SNPs 
in both receptors (glucocorticoid receptor (NR3C 1) and mineralocorticoid receptor (NR3C2)) 
have been associated with changes in basal cortisol levels, and additionally with changes 
in the HPA axis function induced by the Trier Social Stress Test23-25• Therefore, it might be 
likely that the effect of stress exposure on asthma development is modified by the NR3C 1 
or NR3C2. In chapter 6, we tested whether SNPs in NR3C1 or NR3C2 influence asthma 
risk. In addition, we tested whether the effect of these SNPs on asthma development is 
dependent of exposure to perinatal stress. We found no association between SNPs in 
NR3C 1 and asthma in two independent large cohorts. In addition, also SNPs in NR3C2 
were not associated with asthma in our cohorts. Moreover, we found no effect of perinatal 
stress exposure on the association between SNPs in NR3C1 or NR3C 1 and asthma. 
As stated before, the effect of SNPs on asthma development are mostly modest and by 
combining the effect of SNPs a better prediction of the genetic susceptibility of the NR3C1 
and NR3C2 on asthma development is achieved. Therefore, further studies are needed with 
these SNPs combined in a GRS on asthma development in order to investigate the role of 
perinatal stress exposure on this association. 
THE MECHANISMS UNDERLYING THE STRESS-ASTHMA 
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The previous section showed that exposure to psychosocial stress is a risk factor for 
asthma development. However, the mechanisms via which psychosocial stress leads to 
asthma development remain to be clarified. Stress exposure may exert its influences on 
many levels, making it difficult to disentangle the different mechanisms underlying this 
stress-asthma association, such as the stress systems (H PA axis and ANS) and health-risk 
behaviors. In this section, we discuss the role of the HPA axis and health-risk behaviours 
such as in utero exposure to maternal smoking as mediating mechanisms in the association 
between psychosocial stress exposure and asthma development. 
The role of the HPA axis in the association between stress and asthma development 
Most studies that investigated the role of the HPA axis use cortisol as measure for the 
functioning of the HPA axis. In these studies, cortisol is mostly collected in saliva, because 
it is a noninvasive stress-free sampling procedure that permits the monitoring of HPA axis 
functioning in an individual's natural environment26• Moreover, salivary cortisol values reflect 
the biologically active, unbound fraction of cortisol, and have a high correlation with serum 
cortisol27• In humans, cortisol secretion follows a circadian rhythm, with a sharp increase 
prior to awakening, reaching a peak approximately half an hour later (cortisol awakening 
response (CAR)28•29) ,  after which the secretion of cortisol steadily declines and is at its 
lowest during midnight. During exposure to psychosocial stress, the secretion of cortisol on 
top of this circadian secretion is increased. 
Since cortisol can induce a shift in the Th1ffh2 balance towards a Th2 inflammatory 
response, the HPA axis can be one of the potential mechanisms via which psychosocial 
stress can lead to asthma development. A previous study in the TRAILS cohort investigated 
the association between stressful life events and cortisol levels (before, directly after, 20 
minutes and 40 minutes after a stress test) in 715 adolescents at age 16 years30• This study 
showed that exposure to perinatal stress is associated with increased cortisol reactivity 
upon stress. In addition, this study found that exposure to adversities during ages 6-11 
years was associated with overall higher cortisol levels, especial ly in those exposed to 
perinatal adversity, while exposure to adversities during ages 12-13 and 14-15 were 
associated with overall low cortisol levels. These results showed that there is an effect 
of stress on cortisol levels during adolescence which depends on the timing of the stress 
exposure. Therefore, it is plausible that changes in cortisol are responsible for the effect 
of stress on asthma. However, what is the direction of this association? Since increased 
cortisol levels lead to a predominant Th2 response of the immune system, one might expect 
that high cortisol levels are protecting against asthma. However, a recent review stated 
that a blunted HPA axis (characterized by lower morning cortisol levels and flattening of 
the diurnal slope) is associated with an increased susceptibility to develop autoimmune 
and inflammatory diseases31 • Therefore, another hypothesis is that asthma is associated 
with lower cortisol levels. How this low cortisol levels lead to the development of asthma is 
yet unclear31 • Results from previous cross-sectional studies did not consistently answer the 
question whether asthma is associated with higher or lower cortisol levels. These studies 
found lower32-34, comparable35•38 and also higher39•40 cortisol levels in asthmatics compared 
to non-asthmatics. Therefore, we performed a meta-analysis on these studies to integrate 
previous findings on the association between cortisol and asthma. This meta-analysis 
revealed that morning and evening cortisol levels are lower in asthmatics compared to 
non-asthmatics, however, the summary effect estimates are not significant (Figures 5.1 
and 5.2). Moreover, funnel plots of the included studies suggest the presence of publication 
bias (Figures E5.1 and E5.2 in online supplement). There was especially a lack of studies 
showing negative associations between cortisol levels and asthma in the literature. Thus, it 
still remains unclear whether there is an association between cortisol and asthma. 
In chapter 5, we investigated the association between basal and stress-induced cortisol 
and asthma. In addition, we investigated the association between basal cortisol and 
asthma development in a longitudinal study design. Despite having the largest sample size 
published, our study did not find any significant association between basal or stress-induced 
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cortisol and asthma, which indicates that the HPA axis functioning in asthmatic adolescents 
is not different from that in non-asthmatic adolescents. Moreover, our study did not find 
any association between basal cortisol and asthma development. Several explanations can 
be given for the fact that we failed to find any significant association between cortisol and 
asthma or asthma development. 
Heterogeneity in asthma phenotypes 
The asthma populations described in previous cross-sectional studies were heterogeneous 
in terms of asthma phenotypes. Some studies used asthma as main outcome, and made no 
distinction between different asthma phenotypes, such as early onset allergic asthma/non­
allergic asthma or nocturnal/non-nocturnal asthma. This is important because it is plausible 
that different mechanisms underlie different asthma phenotypes. For example, allergic 
asthma is associated with a Th2 response, which is less prominent in non-allergic asthma. 
Therefore, one could hypothesize that allergic asthma is associated with increased cortisol 
levels, whereas non-allergic asthma is not. Results from one previous study indicated that 
indeed allergic asthma was associated with lower cortisol levels33• This study showed that 
cortisol levels were lower in allergic asthmatics compared to healthy controls. However, 
most studies investigating individuals with allergic asthma did not find lower cortisol levels 
in allergic asthmatics compared to healthy controls, but found comparable35•38 or even 
higher39 cortisol levels in allergic asthmatics. Although the TRAILS study does not have 
detailed information about different asthma phenotypes, information about the presence of 
allergy, hay fever and eczema is available which might give an indication whether asthmatic 
adolescents in our study had allergic (asthma with allergy, hay fever or eczema) or non­
allergic asthma (asthma without allergy, hay fever and eczema). In agreement with the 
literature, we found that cortisol levels are comparable in adolescents with allergic and 
non-allergic asthma. Nocturnal asthma is another phenotype of asthma that might be linked 
to lower cortisol levels, especially during midnight. Only one study previously investigated 
cortisol levels in nocturnal asthmatics, non-nocturnal asthmatics and healthy subjects40 • 
This study found higher cortisol levels in individuals with nocturnal and non-nocturnal 
asthma compared to healthy ones. Further studies are needed, with detailed phenotyping 
of asthma, to investigate whether specific asthma phenotypes are associated with HPA axis 
alterations. 
Next to detailed phenotyping of asthma, it is also important that these future studies take 
asthma severity into account. One previous study investigating 12 time points during a 24-
hour period found that the acrophase in cortisol secretion (the increase in cortisol secretion) 
was delayed with 2 hours in adults with mild asthma and with 8 hours in adults with moderate­
to-severe asthma32• Moreover, asthmatics, especially the more severe ones, are treated 
with corticosteroids. This is important since it is known that corticosteroid treatment lowers 
the endogenous cortisol production41 via the negative feedback mechanism that regulates 
the cortisol production in the human body. Including asthmatics using corticosteroid 
treatment into the study could thus confound the association between cortisol levels and 
asthma. Therefore, it is preferable to investigate asthmatics using corticosteroids separately 
from asthmatics not using this treatment when studying the association between cortisol 
levels and asthma. Most previous studies excluded asthmatics on corticosteroid treatment. 
These studies found lower32·33 , comparable35•37 and higher39·40 cortisol levels in asthmatics 
compared to non-asthmatics. A close comparison of these studies reveals that all studies 
used different time points at which their asthmatics were not allowed to take corticosteroid 
treatment, ranging from no treatment at all to no treatment with corticosteroids within the 
last 3 months prior to the start of the study. In chapter 5, where we studied the association 
of cortisol with asthma and with asthma development, we performed sensitivity analysis to 
investigate the confounding role of corticosteroid treatment on these associations. We found 
that excluding adolescents using corticosteroids did not essentially change our results. 
Drawbacks of cortisol assessment in population based studies 
Because cortisol secretion follows a circadian rhythm, a day-time cortisol profile is preferable 
over cortisol measures at one specific time point (i.e. the cortisol awakening response)26• 
Moreover, a recent review stated that a blunted HPA axis (characterized by lower 
morning cortisol levels and flattening of the diurnal slope) is associated with an increased 
susceptibility to autoimmune and inflammatory diseases31 • This emphasizes the important 
role of collecting a day-time cortisol profile, since asthma is a chronic inflammatory disease. 
However, collecting a day-time profile is not always feasible because it is relatively expensive 
and time consuming. Previous studies all used different time points for collecting cortisol 
samples. Some studies collected a day-time cortisol profile (i.e. 12 time points during a 24-
hour period, every 4 hour during a 24-hour period, every 2 hours during a 24-hour period or 
4 samples during a 24-hour period at 2 days}32•33•39A0, whereas others assessed cortisol in 
samples collected at specific time points (i.e. one time point, cortisol awakening response 
(CAR) on 3 consecutive days, one morning sample and one sample 1 hour after the last 
feeding or post-awakening and before bedtime)34-38• Thus, previous studies investigated 
different aspects of the circadian rhythm in relation to asthma development, which makes 
their results difficult to compare. In chapter 5, we tested whether basal cortisol levels (CAR 
and cortisol at 20.00 h) are associated with asthma or asthma development. We found no 
association between CAR and asthma or asthma development. Moreover, we found no 
association between evening cortisol and asthma or asthma development. One previous 
study investigated CAR in asthmatics and non-asthmatics35• Results from this study are 
comparable with our results, namely no differences in CAR between asthmatics and non­
asthmatics. Two studies investigated the association between evening cortisol levels and 
asthma36•38• Although the timing of the evening cortisol samples differed between these two 
studies and our study, results from these two studies were comparable to ours, namely, 
that there was no association between evening cortisol levels and asthma. Based on 
these results, it seems that neither the CAR nor evening cortisol levels are associated with 
asthma. Altogether, studies so far could draw no conclusion on whether other aspects of the 
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circadian rhythm of cortisol secretion (e.g. a flattening of the diurnal slope) are associated 
with asthma. Studies assessing day-time cortisol profile in relation to asthma mostly studied 
a 24-hour mean cortisol level. These studies found lower32•33 as well as higher39 24-hour 
mean cortisol levels. A close comparison of these studies reveals that cortisol samples 
were assessed at different time points in eac h study. Because cortisol secretion follows a 
circadian rhythm, measuring cortisol at different time points results in different cortisol levels 
which has consequences for the calculation of the 24-hour mean cortisol level in saliva or 
blood. In addition, also the amount of cortisol measures during this 24-hour period differed 
between these studies, and this has additional consequences for the 24-hour mean cortisol 
level in saliva and blood due to the circadian secretion of cortisol. This makes results from 
individual studies difficult to compare. Another study compared 12 time points during a 24-
hour period (measured every 2 hours, started at 8.00 h) between non-nocturnal asthmatics, 
nocturnal asthmatics and healthy controls40• This study revealed that overall the cortisol 
levels in non-nocturnal and nocturnal asthmatics were higher compared to healthy controls. 
When comparing the individual time points, this study showed that non-nocturnal asthmatics 
had significantly higher cortisol levels compared to nocturnal asthmatics at 08.00 h and 
10.00 h and at 4.00 h, 6.00 h, 8.00 h, 10.00 h and 12.00 h compared to the healthy controls. 
In addition to the problems discussed above, cortisol levels are also influenced by 
many factors, including age, sex, BM I, depression, physical exercise, smoking and oral 
contraceptive use26•27•42•43• Studies that specifically adjusted for some of these variables, 
mostly sex and age33•34•36, found lower33 •34 or comparable36 cortisol levels in asthmatics 
versus non-asthmatics. In our study, we adjusted for all variables mentioned above and 
found that these variables do neither confound the association between basal or stress­
induced cortisol and asthma, nor the association between basal cortisol levels and asthma 
development, suggesting that that the contradicting findings can not be explained by these 
variables. 
The role of psychosocial stress in the cortisol-asthma association 
One previous study investigating the association between asthma and cortisol levels 
in children age 7-10 years accounted for exposure to psychosocial stress44• This study 
found that cortisol levels were lower in asthmatic children compared to healthy children. 
However, this association was not significant. In addition, this study showed that exposure 
to maternal distress during the first year of life resulted in significantly higher cortisol levels. 
In comparison with children with no history of asthma or maternal distress, exposure to 
recurrent maternal distress resulted in higher cortisol levels in children without asthma, 
whereas in children with asthma, exposure to recurrent maternal distress resulted in lower 
cortisol levels. Moreover, within children with asthma, lower cortisol levels were found in 
children exposed to recurrent maternal distress than in those not exposed44• In this thesis, 
we found that exposure to stress, especially during the perinatal period and first years of life, 
is associated with an increased risk for asthma development (chapter 4). Although previous 
studies suggest a role for cortisol in explaining the association between exposure to stress 
and asthma development, our study failed to find any significant association between 
cortisol and asthma or asthma development. Further studies that take exposure to stress 
during the perinatal period and early childhood into account should reveal whether cortisol 
levels are lower, especially in those adolescents with asthma that are exposed to stress 
during one or more of these periods. 
The role of behavioural stress in the association between stress and asthma 
development 
Exposure to psychosocial stress increases the likelihood of health-risk behaviors such as 
smoking and behaviors related to overweight (both eating and activity patterns). Exposure 
to psychosocial stress is associated with continuing smoking during pregnancy45·46, a known 
risk factor for asthma development in the offspring47• Adolescents with a history of stressful 
events early in life are more likely to smoke regularly4B, which is another known risk factor 
for asthma49• Exposure to early life trauma is also associated with obesity later in life50, again 
a risk factor for asthma51 • Thus, smoking and overweight are potentially mediating factors 
in the relation between early life stress and asthma development. In chapter 4, we found 
that exposure to perinatal stress and exposure to stressful life events early in life are risk 
factors for the development of asthma. Moreover, we explored the role of in utero exposure 
to maternal smoking and birth weight as mediating factors in the association between 
psychosocial stress and asthma development. We found that in utero exposure to maternal 
smoking slightly decreases the HR of the association between in utero exposure to maternal 
psychological problems and asthma development from birth onward, indicating that a small 
part of the effect of prenatal stress exposure on asthma development is explained by in 
utero exposure to maternal smoking. However, we did not find an effect of birth weight on 
the association between prenatal stress exposure and asthma development. Whether other 
health-risk behavior factors are mediators in the association between exposure to early life 
stress and asthma needs to be investigated in further studies. 
CLINICAL RELEVANCE 
Results from this thesis show that prenatal stress exposure and exposure during early life 
are associated with an increased risk for asthma development. However, the mechanisms 
via which stress exposure leads to asthma development are not fully understood yet. 
Health-risk behaviors such as in utero exposure to maternal smoking appear to play a role 
in the association between stress exposure and asthma development. 
Although stress exposure is not preventable, individuals can be made aware of the potential 
deleterious effect of stress on asthma development. Counseling programs may help in this 
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respect by focusing on awareness of the potential effects of stress and on ways to deal with 
stress exposure in order to reduce subjectively experienced stress and thereby possibly 
contributing to prevention of asthma development and to reduction of its severity. Such 
counseling programs might be targeted at pregnant women, midwifes, caregivers, teachers, 
children, adolescents and adults. 
SUGGESTIONS FOR FUTURE RESEARCH 
This thesis showed that exposure to stress during the perinatal period and early childhood 
is associated with asthma. However, some issues remain to be solved by future studies. 
An ideal study should include women at the beginning of their pregnancy, and follow their 
offspring for a prolonged time. Next to already known risk factors for asthma development, 
such as air pollution, it is important to measure maternal exposure to psychosocial stress 
(both the objective exposure to stressors and the subjective experience of stress) and 
maternal mood and maternal smoking with validated questionnaires at multiple times 
during pregnancy. In addition, after birth, it is also important to measure psychosocial stress 
(objective and subjective stress) with standardized questionnaires at multiple times during 
the first years of life, since it is known that caregiving experiences during early childhood 
can influence the development of the HPA axis52. Exposure to stressful life events, 
asthma (including detailed information about specific phenotypes), atopy and life habits 
should be assessed preferably every year from birth onwards in these children, also using 
standardized questionnaires. With this information, the role of specific stressors on asthma 
128 development can be studied. Moreover, the questions whether there is a critical period for 
the effect of stress on asthma development, i.e. the perinatal period, and whether there is 
an accumulative effect of stress exposure on asthma development can be studied. 
To study the role of the mediating mechanisms via which stress leads to asthma development, 
it is important to collect saliva multiple times during several days every year to determine 
cortisol levels as measure of HPA axis activity. 
CONCLUSIONS 
Historically, asthma has been defined as a psychosomatic disorder. However, with the 
understanding of the chronic inflammatory processes underlying asthma, researchers almost 
unanimously discarded the role of psychological factors in asthma development. In the 
last decade, the role of stress on asthma development has been reconsidered. Nowadays, 
psychosocial stress seems to be one of the risk factors next to genetic susceptibility and 
environmental exposures that may contribute to asthma development. Results from this 
thesis showed that especially exposure to psychosocial stress in the perinatal period and 
early childhood is a risk factor for asthma development. Whether the effect of psychosocial 
stress exposure on asthma development is modified by the genetic make-up of an individual 
is yet not clear. Further studies are needed into this intriguing field of research to elucidate 
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The aims of this thesis were to unravel the paths from early life stress to the development 
of asthma up to adolescence, and to quantify the relative contribution of the mediating 
mechanisms via which stress leads to asthma development. We first focused on the role of 
pubertal development on the gender-related switch in asthma prevalence and risk factors 
for the development of asthma. 
Chapter 1 describes asthma and the risk factors contributing to asthma development. One of 
these risk factors is exposure to psychosocial stress. The results of studies investigating the 
role of exposure to psychosocial stress on asthma development were discussed as well as 
the mechanisms via which exposure to psychosocial stress leads to asthma development. 
Additionally, the aims and the research questions of this thesis were described. 
Chapter 2 describes the development of asthma up to adolescence. Specifically, the role 
of age and pubertal development on the gender-related switch in asthma prevalence were 
studied. In addition, the association between pubertal development and asthma-related 
phenotypes, such as total lgE and in peak expiratory flow (PEF) during a shuttle run test 
(SAT) were studied. This study showed that the prevalence of asthma is similar in boys 
and girls at a mean age of 11 years. The prevalence of asthma was significantly higher in 
female than male subjects at mean age 16 years. There were no significant associations 
between transition of pubertal stages and the presence of asthma, either cross-sectionally 
or longitudinally. Pubertal stages and total lgE levels or PEF fall during a SAT at age 16 
years were not related. The conclusion of this study was that a shift in the prevalence of 
asthma occurs between age 11 and 16 years, which is due to both an increased incidence 
and decreased remission of asthma in female compared with male subjects. 
In chapter 3, early life risk factors for asthma development were studied. These include the 
combined effect of SNPs in genes (genetic risk score (GAS)) involved in the development of 
asthma and asthma-related phenotypes on asthma development. The predicting properties 
of this GAS were compared to the predicting properties of known early life risk factors for 
asthma development such as in utero exposure to maternal smoking and maternal asthma. 
This study showed that both the GAS as well as in utero exposure to maternal smoking 
and maternal asthma were associated with asthma. Moreover, GAS remained significantly 
associated with asthma after adjustment for these common risk factors. There was no 
significant interaction between GAS and the common risk factors. The conclusion of this 
study was that the GAS is a highly significant independent predictor of asthma. Its merits 
should be further explored on its potential in clinical and screening practice. 
In chapter 4, the role of exposure to perinatal stress and stress during early childhood on 
asthma development up to adolescence was studied. Results from this study show that in 
utero exposure to psychosocial stress and exposure to stressful life events (family member 
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or another close person, parental divorce, and the child not living with their parents for at last 
three months) before 4 years of age were significantly associated with asthma development 
up to age 1 6  years; exposure to postnatal stress approached significance. Moreover, we 
found that the risk to develop asthma as a result of exposure to stress decreased with the 
passage of time. In conclusion, this study showed that exposure to prenatal stress and 
stressful life events experienced before 4 years increased the risk of asthma development. 
Chapter 5 and 6 focused on the role of the HPA axis on asthma and asthma development. 
In chapter 5 the association between (1 ) cortisol levels and asthma or asthma development 
and (2) cortisol levels upon stress and asthma were studied . In addition, a meta-analysis 
was performed on results from the literature. Results from this study suggest no significant 
association between cortisol and asthma (age 1 1  years) or asthma development (age 1 4  
or 1 6  years). I n  addition, no association was observed between level of cortisol upon stress 
and asthma (age 1 6  years). The meta-analysis showed there were lower morning and 
evening cortisol levels in asthmatics compared to non-asthmatics, however, the summary 
estimates were not significant. 
In chapter 6, the association between SNPs in NR3C2 or NR3C1 and asthma development 
was studied in two independent cohorts. Additionally, interactions between genotype and 
perinatal stress were tested in TRAILS. Results from this study showed that there is no 
association between SNPs in NR3C2 or NR3C1 and asthma in two independent cohort 
studies. I n  addition, no significant interaction between genotype and exposure to perinatal 
stress was found. 
In chapter 7 the answers to the main research questions of this thesis were summarized. 
138 The results were discussed and methodological considerations and recommendations 
were made. In conclusion, this thesis showed that prenatal stress exposure and exposure 
during early life were associated with an increased risk for asthma development. 
However, the mechanisms via which stress exposure leads to asthma development are 
not fully understood yet. Health-risk behaviors such as in utero exposure to maternal 
smoking appear to play a small role in the association between stress exposure and 
asthma development. More research is needed that explores both physiological as well 
as behavioral stress effects as explanation for the link between stress and asthma. 


NEDERLANDSE SAMENVA TTING 
Astma is een chronische ontstekingsziekten van de luchtwegen en longen. lemand 
met astma is gevoelig voor prikkels waar gewone mensen niet gevoelig voor zijn, zoals 
bijvoorbeeld sigarettenroak, mist en huisstofmijt. Blootstelling aan deze prikkels zorgt 
voor een ontstekingsreactie in de luchtwegen wat resulteert in een variabele, meestal 
reversibele, luchtwegobstructie. Patienten met astma hebben klachten als piepen, hoesten, 
benauwdheid en kortademigheid. 
De laatste jaren is gebleken dater een toe name is van het aantal mensen dat astma ontwikkelt. 
Een genetische achtergrond kan dit niet makkelijk verklaren. Ook de reeds bekende 
omgevingsfactoren, zoals de blootstelling aan allergenen, sigarettenrook, huisstofmijt, of 
het hebben van een moeder met astma, kunnen deze toename van het aantal mensen dat 
astma ontwikkelt niet verklaren. Vandaar dat er de laatste jaren onderzoek wordt gedaan 
welke andere risicofactoren kunnen bijdragen aan het ontwikkelen van astma. Eem van 
de risicofactoren is de blaotstelling aan psychosociale stress, de spanning die ontstaat 
wanneer iemand de eisen die de omgeving aan hem stelt niet meer aan kan. 
In dit proefschrift wordt onderzocht of blootstelling aan psychosociale stress de kans op 
het ontstaan van astma vergraot. Tevens worden de mechanismen anderzocht die hierbij 
een rol zouden kunnen spelen. De onderzoeken in dit proefschrift maken deel uit van de 
TRacking Adolescents' Individual Lives Survey (TRAILS). Het TRAILS onderzoek is een 
grootschalig prospectief onderzoek waarin 2230 jongeren uit de drie noordelijke provincies 
van Nederland vanaf hun 10° tot hun 25° levensjaar gevolgd warden. Voor dit proefschrift 
werden de eerste drie metingen gebruikt waarin de kinderen gemiddeld 11 , 14 en 16 jaar 
oud waren. 
In hoofdstuk 2 wordt de relatie tussen puberteitsstadia en geslachtsverschillen in de 
ontwikkeling van astma onderzocht. Uit dit onderzoek blijkt dat op 11- en 14-jarige leeftijd 
evenveel jongens als meisjes astma hebben. Echter op 14- en 16-jarige leeftijd hebben meer 
meisjes astma ontwikkeld, terwijl bij de jongens de astma klachten juist zijn verminderd. 
Vervolgens is onderzocht of geslachtsverschillen in het v66rkomen van astma parallel 
lopen met de verandering in puberteitsstadia tussen 11- en 16-jarige leeftijd. Daarnaast is 
onderzocht of puberteitsstadia op 16-jarige leeftijd samenhangen met astma gerelateerde 
kenmerken (totaal lmmunoglobuline E (lgE) en een daling van de piekstroommeting (PEF) 
na een shuttle run test (SAT)). Resultaten van dit onderzoek laten zien dat er geen verband 
is tussen veranderingen in puberteitsstadia en het v66rkomen van astma. Ook is er geen 
verband gevonden tussen puberteitsstadia en totaal lgE of PEF na SAT. We concluderen 
uit deze studie dat geslachtsverschil len in de ontwikkeling van astma niet verklaard kunnen 
warden door puberteitsstadia. 
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In hoofdstuk 3 wordt onderzoek gepresenteerd naar interleukine (IL) 4, IL4 receptor (/L4R), 
IL 13, E-cadherin (CDH1), Protocadherin-1 (PCDH1) en A DisintegrinAndMetalloprotease 
33 (ADAM33). Single Nucleotide Polymorphisms (SNPs) in deze genen zijn in eerdere 
studies geassocieerd met astma of astma gerelateerde kenmerken, zoals het optreden van 
allergie, verstoorde epitheelcel-functie en toename in remodellering van de luchtwegen. 
Door het combineren van SNPs in een genetisch risico score (GAS) is het mogelijk een 
groter deel van het risico op het ontwikkelen van astma te kunnen verklaren. In hoofdstuk 
3 is de voorspellende waarde van de GAS voor het ontwikkelen van astma vergeleken 
met de voorspellende waarde van andere bekende risicofactoren van astma zoals roken 
gedurende de zwangerschap en het hebben van een moeder met astma. Daarna is 
onderzocht of genetische kwetsbaarheid, zoals gereflecteerd in de GAS, het effect van 
bekende risicofactoren op het ontwikkelen van astma beTnvloedt. Aesultaten van deze 
studie laten zien dat de GAS, roken gedurende de zwangerschap en het hebben van een 
moeder met astma geassocieerd zijn met het ontwikkelen van astma. Na het corrigeren 
voor roken gedurende de zwangerschap en het hebben van een moeder met astma is 
de GAS nog steeds geassocieerd met het ontwikkelen van astma. Daarnaast is er geen 
significante interactie gevonden tussen de GAS en roken gedurende de zwangerschap of 
het hebben van een moeder met astma. Hieruit kunnen we concluderen dat het effect van 
GAS op het ontwikkelen van astma in adolescenten onafhankelijk is van roken gedurende 
de zwangerschap of het hebben van een moeder met astma. 
In hoofdstuk 4 wordt de relatie tussen blootstelling aan psychosociale stress en het 
ontwikkelen van astma onderzocht. Eerdere studies hebben aangetoond dat zowel de kans 
op het ontwikkelen van astma-exacerbaties als de kans op ziekenhuisopname ten gevolge 
van deze exacerbaties is vergroot na blootstelling aan psychosociale stress. Welke rol 
psychosociale stress in de ontwikkeling van astma speelt is minder duidelijk. Aesultaten van 
deze studie laten zien dat blootstelling van de moeder aan psychosociale stress gedurende 
de zwangerschap de kans op het ontwikkelen van astma in het kind tot de leeftijd van 16 jaar 
vergroot. Deze kans is ook verhoogd na de blootstelling aan stressvolle gebeurtenissen in 
de eerste vier levensjaren (zoals het overlijden van een familielid, scheiding van de ouders 
en het niet thuis wonen gedurende tenminste 3 maanden). Het effect van blootstelling aan 
psychosociale stress op het ontwikkelen van astma wordt kleiner naarmate de leeftijd waarop 
de blootstelling aan psychosociale stress toeneemt. Vervolgens is in deze studie gekeken 
of roken gedurende de zwangerschap en geboortegewicht een deel van het verhoogde 
risico op het ontwikkelen van astma als gevolg van de blootstelling van de moeder aan 
stress tijdens de zwangerschap kan verklaren. Aesultaten van dit onderzoek laten zien dat 
roken gedurende de zwangerschap inderdaad een klein deel van het effect van stress op 
het ontwikkelen van astma verklaart. Voor geboortegewicht is dit niet het geval. 
In hoofdstuk 5 wordt de rol van basaal cortisol in astma en astma ontwikkeling onderzocht. 
Bij stress nemen de concentraties van het stress-hormoon cortisol toe. Cortisol be"invloedt 
onder andere het immuunsysteem en zou daarmee de kans op astma kunnen verhogen 
of verlagen. Het is nog steeds onduidelijk of astma nu gepaard gaat met een verhoogde, 
dan wel een verlaagde cortisolconcentratie in het bloed. Daarnaast is de rol die cortisol 
speelt in de ontwikkeling van astma nooit eerder onderzocht. Op de leeftijd van 1 1  jaar is 
onderzocht of cortisolconcentraties direct na het ontwaken geassocieerd zijn met astma. 
Daarnaast is onderzocht of cortisolconcentraties na een stress test afgenomen op 1 6-jarige 
leeftijd geassocieerd zijn met astma. Resultaten van dit onderzoek laten zien dat er geen 
verband is tussen cortisolconcentraties, zowel direct na het ontwaken als na de stress test, 
en astma. Vervolgens is onderzocht of cortisolconcentraties direct na het ontwaken op 
1 0-jarige leeftijd geassocieerd zijn met het ontwikkelen van astma op 1 4- en 1 6-jarige leeftijd. 
Resultaten van dit onderzoek laten zien dat er geen verband is tussen cortisolconcentraties 
na het ontwaken en de ontwikkeling van astma. Om de vraag toch te beantwoorden of 
astma gepaard gaat met verhoogde of verlaagde cortisolconcentratie is een meta-analyse 
uitgevoerd op resultaten beschreven in de literatuur. Deze meta-analyse laat zien dat zowel 
de ochtend- als de avond-cortisolconcentraties lager zijn in mensen met astma ten opzichte 
van gezonde mensen, maar de verschillen zijn niet significant. De conclusie van de studie 
in ons cohort van jonge mensen rond de puberteit is dus dat er geen bewijs is dat cortisol 
een rol speelt in astma en de ontwikkeling van astma. 
Hoofdstuk 6 onderzoekt SNPs in receptoren die cortisol binden, namelijk de 
mineralocorticoid en glucocorticoid receptor. Via binding aan deze receptoren beTnvloedt 
cortisol het immuunsysteem. SNPs in deze receptoren (mineralocorticoid receptor (NR3C2); 
glucocorticoid receptor (NR3C1)) zijn geassocieerd met veranderingen in basale cortisol 
concentraties en met veranderingen in cortisol concentraties als gevolg van blootstelling aan 
een stress test. Twee eerdere studies vonden dat SNPs in NR3C1 ((rs61 95, rs41 423247) 
geassocieerd zijn met de ontwikkeling van astma, maar resultaten van deze studies zijn 
nooit gerepliceerd. De rol die SNPs in NR3C2 hebben in de ontwikkeling van astma is 
nooit eerder bestudeerd. In hoofdstuk 6 is onderzocht wat de rol van SNPs in NR3C2 en 
NR3C1 is in de ontwikkeling van astma. Daarnaast is in deze studie onderzocht of het effect 
van SNPs in deze receptoren in de ontwikkeling van astma afhangt van de blootstelling 
aan perinatale stress. Resultaten van deze studie laten geen verband zien tussen SNPs 
in NR3C2 en NR3C1 en astma. Tevens zijn er geen aanwijzingen gevonden voor een 
interactie tussen SNPs in NR3C2 en NR3C1 en blootstelling aan perinatale stress. Dit 
suggereert dat genetische varianten in de mineralocorticoid en glucocorticoid receptor geen 
aantoonbare rol spelen in de ontwikkeling van astma. 
Psychosociale stress is een risico factor voor het ontwikkelen van astma. Echter de 




Voor u ligt het proefschrift "The role of stress in the etiology of asthma' waaraan ik de 
afgelopen 4 jaar heb gewerkt. Velen hebben een bijdrage geleverd aan het tot stand komen 
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Gedurende de 4 jaar van mijn promotie heb ik vele collega's ontmoet. Collega's van de 
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vrienden en (schoon)familie bedanken voor hun steun, interesse en gezell ige tijden 
gedurende deze 4 jaar. En natuurlijk wil ik mijn paranimfen Karen en Wessel bedanken. 
Lieve Karen, naast alle leuke dingen die we de afgelopen jaren hebben gedaan wit ik je in 
het bijzonder bedanken voor de steun, interesse en adviezen die je me gegeven hebt. Lieve 
Wessel, jouw levensinstell ing, steun, geduld en liefde hebben ervoor gezorgd dat ik tijdens 
mijn promotie met name de dalen altijd weer kon relativeren. Bedankt dat jul lie mij bij willen 
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